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CHAPTER I 
INTRODUCTION 
High quality data are essential to the accuracy and validity of clinical study results. Assuring data 
quality has been a particular emphasis of clinical trials, where extensive personnel training and data 
monitoring programs are built into the study protocol in an effort to prevent scientific misconduct and 
ensure compliance with the International Conference on Harmonization’s guidelines for Good Clinical 
Practice [1]. Yet clinical trials can be elaborate and expensive and the cohorts are not always large or 
varied enough to answer broad research questions. As a result, researchers and funding agencies seek 
to leverage existing clinical care data by pooling datasets from multiple sites [2]. Indeed, the United 
States of America’s National Institutes of Health (NIH) have indicated an interest in promoting and 
expanding such clinical research networks by featuring them as a cornerstone of the NIH Roadmap for 
Medical Research [3,4]. The U.S. Nationwide Health Information Network, a standards initiative for 
health information exchange over the Internet, supports complementary standards for both clinical care 
and clinical research data in order to encourage and support the reuse of healthcare data for 
observational studies and population monitoring [5].   
Medical research is experiencing a simultaneous upsurge in international research 
collaborations [6,7]. Membership in multi-national research networks has grown exponentially and 
publications by multi-national research teams receive more citations than similar work from domestic 
collaborations [8,9]. These trends combine in the increased reuse of clinical care data for international 
research collaborations. Data collected during routine patient care are readily available and relatively 
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inexpensive to acquire [10], so even clinical sites in resource-limited settings are contributing data to 
shared repositories or multi-site datasets [11,12].  
Unfortunately scientists seldom investigate the quality of such “secondary use” data as 
thoroughly as data generated in clinical trials or similarly regulated studies [13]. Some research groups 
rely on data cleaning performed at the data coordinating center to detect data discrepancies, or request 
that their participating sites perform regular quality self-assessments [14,15]. Given time and funding 
restrictions and a dearth of data management personnel in academic centers, it is likely many groups 
simply accept secondary use data as is. 
We believe significant challenges to high quality data exist within such international, multi-site 
research networks, but that these issues can be remedied through well-planned, cost-effective quality 
control activities. Our projects investigate the necessity of data quality assessments for observational 
networks, as well as means of identifying and evaluating data errors and improving the audit process. 
This work encompasses four aims:  
 
Aim 1: Evaluate through a series of source verification data audits the accuracy and 
completeness of observational data submitted to an international, multicenter HIV research 
network;  
Aim 2: Investigate reasons for data quality variations, as perceived by the local research teams; 
Aim 3: Develop a computer-based audit tool for source verification data audits; and 
Aim 4: Evaluate data quality dimensions in the context of clinical research data audits. 
  
The findings demonstrate that data quality control activities should not be limited to clinical 
trials and that investigators who reuse clinical care data must be particularly vigilant regarding its 
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quality. The causes of data errors can vary greatly, and collaborative research networks – especially 
those in international settings – should consider implementing an audit program to evaluate the 
reliability of different data sources and correct discrepancies in data that have already been collected. 
Such audits can be made more efficient by using computerized tools and flexible error metrics. 
Dissertation Contents 
This report comprises six chapters describing four associated research aims. This chapter 
(Chapter I) introduces the research problem. Chapter II defines the concept of data quality, provides an 
overview of quality control and data auditing in medical research, and introduces the international, 
multi-site, HIV research network that serves as the setting for the subsequent data quality-related 
projects. The network’s data auditing process and the findings from the first seven site audits are 
discussed in Chapter III, along with the audit team’s recommendations for data quality improvement. 
Chapter IV presents the varied reasons for data errors at each network site, as elicited from clinicians 
and data entry personnel by an anonymous survey. We explore the feasibility of improving such audits 
using computer-assisted auditing tools in Chapter V. Chapter VI discusses extant error taxonomies used 
in data auditing and the types of information they failed to capture during our on-site audits, while 
identifying additional relevant dimensions of data quality. The concluding chapter (Chapter VII) 
summarizes the research findings and discusses additional directions for this work.  
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CHAPTER II 
BACKGROUND 
Definitions of Quality 
The value of conclusions drawn from data relies heavily, though not exclusively, on the data’s 
quality. High quality data are crucial to sound decisions in diverse domains, including financial 
transactions, political and military policy, product manufacturing, patient care, and biomedical research. 
Yet scientists and government regulators have hitherto not adopted a universal definition of data 
quality. The U.S. Department of Health and Human Services’ "Guidelines for Ensuring and Maximizing 
the Quality, Objectivity, Utility, and Integrity of Information" – a product of the U.S. Data Quality Act – 
proposed that high quality data were useful to their intended audience, presented in context and in a 
complete and unbiased manner, well-sourced and documented, and secured from tampering or 
unauthorized changes [16]. An alternate definition emerged from the U.S. Institute of Medicine’s 1999 
Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, which stated “’high-
quality data’ refers to data that can be used without further revisions or data that will produce 
conclusions and interpretations that are equivalent to those that would be derived from error-free data, 
that is, data that are accurate, reliable, and fit for use” [17]. Although the International Organization for 
Standardization (ISO) has begun development of a standard for data quality, ISO 8000, applications of its 
as-of-yet-unfinished specifications have received no attention in the scientific literature [18,19].   
The common characteristic among these and other published data quality definitions is that 
data quality is a compound concept. Over twenty-six distinct aspects of quality are described in the 
literature, occasionally with identical names and conflicting definitions [20]. The most frequently 
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reported “dimensions of data quality” include accuracy (the extent to which a recorded data point 
conforms to the true value), completeness (the extent to which necessary data that could have been 
recorded have been recorded), timeliness (the rapidity with which data are entered into the database 
after they are generated), conciseness (the degree to which data have been represented in a compact 
format with minimal redundancy), objectivity (the extent to which data are free from bias), transparency 
(the detail with which the data collection process is described in accompanying documentation, 
supporting information reproducibility), reputation (the degree of trust in the data’s origin), security (the 
extent to which the data have been protected from accidental or malicious manipulation), and relevance 
(the extent to which the data fit the researcher’s needs)[20-25].  
Not every application of data requires high quality measures in each of these dimensions. For 
example, district-level data are unnecessarily precise for a graphic of population size by country, and 
timeliness is an unimportant data quality dimension for a retrospective study of cancer incidence two 
decades ago. In assessments of clinical research data, accuracy and completeness of the dataset are 
considered the most critical markers of data quality. When a dataset registers high quality in all 
dimensions relevant to the researcher, it is deemed “fit for use.” This viewpoint is summarized in Arthur 
Chapman’s Principles of Data Quality: “in a database, the data have no actual quality or value; they only 
have potential value that is realized when someone uses the data to do something useful”[26]. 
Impact of Errors 
Despite disagreements on definitions of high quality data, researchers agree poor quality data is 
costly. When investigators study datasets that are not fit for use, the data’s deficiencies may foil 
analyses, lead to biased conclusions, and possibly trigger expensive quality interventions. In application, 
this misinformation yields manufactured products that fail to meet specifications, ill-tailored business 
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services, and harmful or suboptimal health care. Poor customer data quality, for example, has a negative 
impact on customer-business relationships [27] and a survey by Information Impact International, a U.S. 
consulting firm, indicated low quality data may cost organizations 10% of revenues [28]. In economics, 
data errors have led to misclassification of 34% of countries on the Human Development Index [29]. 
Applications of flawed data can endanger patient health: missing data from electronic patient records 
have caused a clinical diagnostic support system to generate “inappropriate and unsafe 
recommendations” on the risk of gastrointestinal bleeding in 77% of patient encounters [30]. 
Implemented findings from chemotherapy studies using falsified data have resulted in serious patient 
harm [31]. 
Data errors also impact biomedical research. A study by Ancukiewicz et al. assessed the effect of 
medical record abstraction and data entry errors on an analysis of radiation oncology data. An expert 
validation of all variables revealed that 2.7% of data elements contained a data abstraction or entry 
error and that these errors resulted in statistically and clinically significant differences in the survival 
rates of the analyzed cohort [32]. Data entry errors alone, particularly errors in binary variables, can 
corrupt the results of epidemiologic studies [33]. And even moderate error rates of 1-5% in 
phenotype/genotype datasets can obscure the results of genetic linkage and association studies [34,35].  
Quality of Medical Data 
Despite the consequences of error, medical data collections suffer from high rates of incomplete 
and incorrect data and concerns about the quality of medical data are reflected in studies of disease 
registries, electronic medical records, and clinical trials datasets. Cancer registries in Norway, Scotland, 
have reported 1.2% of requested fields are missing and 2.8% contain clinically significant errors [36,37]. 
Extensive reviews of cancer research datasets revealed that 1-2.8% of variables did not match data in 
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the clinical record [38,39]. A survey of antiretroviral therapy (ART) programs in low-income countries 
found on average 10.9% of key patient care variables were missing from the local electronic medical 
database [40]. Similarly, an evaluation of 29 medical record elements available in a Dutch university 
hospital information system found only 19 were usable without manual reformatting or data cleaning 
and that most errors stemmed from inaccurately recorded times of treatment events, missing symptom 
or diagnosis data,  incorrect evaluations of illness severity, and prescription data  [41].  
As illustrated by the Dutch study, some data types may be more prone to error than others. 
Demographic and medication data tend to contain fewer errors than patient problem lists or diagnoses, 
according to a landmark review of data accuracy in electronic medical records [42]. Not all patient intake 
data receives the same attention as demographics, however; lifestyle data such as history of smoking 
and alcohol use, socioeconomic status, patient occupation, and ethnicity are frequently overlooked [43]. 
Within data forms, answer options associated with more complex patient treatments are more prone to 
error, as are data that require interpretation or physician assessment [44]. 
Errors can be introduced during multiple stages of the data collection process. The events that 
cause data distortion or loss include data capture (when data are generated and recorded), record 
abstraction (when data are transcribed from the medical record to a case report form, or CRF), and data 
entry (when data are copied from the form into the study database.) Of these, data abstraction is 
considered the primary source of error, resulting in ten times as many errors as CRF-to-database entry 
[45]. Concerns about medical record abstraction solidified after a 1974 Institute of Medicine report that 
concluded “diagnosis-specific discrepancies [produced by record abstraction] are of sufficient magnitude 
to preclude use of such data for detailed research and evaluation” [46]. More recent studies of data 
abstraction and entry error rates reported 11.5% to 31% of all requested data fields were overlooked, 
improperly interpreted, or incorrectly transcribed [47,48]. 
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Pharmaceutical and medical device companies seeking U.S. government approval for their 
products are held to higher data quality standards, just one to five errors in 1,000 data fields is 
considered an acceptable error rate [49]. 
Quality Control in Medical Research 
The International Conference on Harmonisation (ICH) publishes a standard for ethical and 
scientific quality in clinical trials that involve human participants. These standards, called Good Clinical 
Practice (GCP) principles, were developed in response to exposés of study fraud and pharmaceutical 
trials that led to patient harm [50]. GCP outlines requirements for designing, conducting, and reporting 
the results of clinical trials [1]. For investigators following GCP, quality assurance and control activities 
help to ensure scientific validity, monitor patient safety during clinical trials, catch systematic data 
collection problems and prevent future errors, increase public confidence in the study conclusions, and 
meet requirements for regulatory approval [51]. Studies often conduct duplicate data entry to reduce 
the frequency of typographical errors in the final dataset [52], and may integrate electronic data capture 
software to eliminate paper case report forms. Such software usually includes range and valid value 
checks for data entry as well as automated database checks for internal consistency [53].  
Extensive and regular training of study investigators and staff serves to further reduce errors in 
data collection [54]. Protocols may specify strict adherence to published standard operating procedures 
for patient interaction and data collection and storage. Many multicenter trials support a phone hotline 
for questions from sites and maintain frequent email contact to sustain motivation and attention to 
detail among study personnel [53].  
Source documents are the gold standard for recorded information in a clinical trial [55]. The ICH 
guideline defines them as “original documents, data, and records” from which the study data derive, 
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including hospital records, clinical and administrative office charts, laboratory reports, pharmacy 
dispensing records, recorded data from automated instruments, and records from outside clinics, as 
well as certified copies or transcriptions of such documents [1]. Missing source documents and frequent 
data errors amount to major violations of clinical trials data quality codes [56]. 
As medical record abstraction frequently generates errors, clinical trials that rely on abstraction 
data sometimes implement additional quality interventions, including individual data abstractor training 
sessions, a thorough training manual that accompanies the Standard Operating Procedures for data 
collection, standardized record abstraction examples, on-site visits, occasional double-abstraction 
sessions for pairs of auditors, weekly team conference calls, and a rapid cycle of data submissions from 
sites followed by data cleaning requests from the coordinating center [57]. These interventions 
effectively reduce data error originating from medical record abstraction, but the additional time and 
funding they require ensures that only the most rigorous studies implement such measures. 
Observational research networks face quality challenges that arise from repurposing data 
collected primarily for clinical care. In protocol-driven prospective studies, such as clinical trials, 
methods of error detection include prospective quality assurance activities that take place before and 
during a trial, including case report form design and testing, standardization of data collection tools and 
procedures, and ongoing training of study personnel [58]. Studies using pre-existing data are limited to 
quality control activities that occur once active data collection in a study has ceased, as illustrated in 
Figure 1. 
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Figure 1: Comparison of paper-based data collection in clinical trials and research networks 
This figure illustrates the process of paper-based data collection in prospective clinical trials and in collaborative 
research networks reusing clinical care data. In a clinical trial, all steps of the data generation process are 
supervised by the study coordinators. In a collaborative research network, only the final step of dataset creation – 
the pooling of multiple site datasets at the data coordinating center – is subjected to a standardized process. 
Problems with conflicting data collection methodologies and data quality standards are 
amplified in international and low-resource settings, where different resources and cultural norms affect 
the conduct of research and delivery of healthcare [59]. The more sites differ in their data collection 
procedures and data storage formats, the harder it becomes to merge the data and derive accurate 
study results [60]. 
Data Auditing 
Auditing is an established technique for evaluating and improving the quality of products, 
services, or information, and has been a staple of quality control activities for over a  
century [61,62]. Audits take many different forms depending on the domain: in accounting, they identify 
fraud; in manufacturing, audits help assess both the quality of a product lot and the producer’s 
compliance with Good Manufacturing Practice; and in information security, audits allow for the 
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inspection of the security and reliability of computer systems and of the information they contain 
[63,64].  
In medicine, researchers have employed audit techniques to detect inconsistencies in 
terminologies, evaluate the quality of patient care and verify that medical services are properly 
documented, coded, and billed [65-68]. Audits of health care outcomes in Africa provide insight into 
regional policies on HIV/AIDS care [69]. The U.S. Federal Drug Administration also requires auditing of 
many clinical trials to ensure that the operators of the trial are properly monitoring patient safety, 
accurately recording data generated by the study, and adhering to the study’s protocol and Good 
Clinical Practice [1,70]. The U.S. Veterans Administration conducts manual quality assessments of 
computerized patient records every three months [71,72], while research groups like EuroSida and the 
European Organization for Research and Treatment of Cancer conduct yearly quality monitoring visits at 
centers contributing data to their cohorts [60,73]. 
Under ideal circumstances, clinical data audits are conducted by a team of trained auditors 
following a structured audit methodology for GCP, defined as a “systematic approach to auditing 
characterized by a prescribed, logical sequence of procedures, decisions, and documentation steps, and 
by a comprehensive and integrated set of audit policies and tools designed to assist the auditor in 
conducting the audit”[74]. This group is responsible for determining the goals of the audit, alerting 
auditees, and selecting audit records. 
Once on-site, the audit team conducts a facility tour, interviews the study staff, and inspects the 
study regulatory binder. The majority of the audit is spent reviewing source documents such as the 
clinical record, laboratory reports, and pharmacy records for at least 10% of cases [53]. Auditors 
evaluate whether patient safety has been maintained during the trial and whether study data were 
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collected according to GCP guidelines. During the last day of the on-site visit, auditors complete an audit 
checklist and hold an exit interview with local clinical investigators to present the initial audit findings. 
Barriers to Audit 
Data audits are not cheap. In 2002, a single-site FDA audit for pre-marketing drug approval cost 
on average USD $7,350 for domestic locations, or $9,400 for audits at international sites, and required 
close to 100 auditor hours for preparation, inspection, and report writing [17]. In a large clinical trial 
involving 10,000 patients, 100% audit of all data points could incur costs in excess of two million dollars 
[53]. Resolving errors identified by data review consumes additional time; revising inaccuracies (for 
0.44% of data elements) in 499 records from a head injury database took approximately 15 person 
hours, while filling in missing data (7%) took over 60 person hours [14]. 
However, science is not inherently self-correcting and efficient audits can be a cost effective 
means of identifying flaws in research [75]. Yearly audits of 10-20% of records is a cheaper solution than 
complete audits and still provides a reliably data quality benchmark. Clinical trials investigators have also 
found the cost of audits decreases over time as quality assurance procedures are reinforced during the 
conduct of a trial [53]. 
Local clinicians and data management staff often fail to notice the shortcomings of their data 
collection techniques; external observers can offer feedback that improves the correctness and 
completeness of future data collections [76]. Visiting individual sites in a multi-center research 
consortium also cultivates collegial working relationships among researchers and allows auditors to 
identify organizational and workflow practices that may influence the quality of data collection [60]. 
These insights can affect how individual site datasets are handled during data cleaning and analysis. 
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Academic research studies, however, may involve fewer data quality assurance activities than 
regulated clinical trials conducted by clinical research organizations, possibly because they lacks a 
supervising agency, a standard hierarchy of responsibility and command among investigators, and a 
client to assume the costs of quality assurance [77,78]. Researchers also resist conducting audits 
because they generate extra paperwork, consume funds that could otherwise go to new research, and 
are perceived as being excessive for unregulated studies while implying distrust of researchers’ 
commitment, ability, and ethics [77]. Lack of time and motivation among investigators, unclear audit 
procedures, and difficulties with staff coordination frequently factor in the failure of voluntary audit 
programs [79].  
Proposals to enforce routine auditing in academia include conducting independent audits of the 
scientific literature to ensure the validity of study results and the integrity of fellow investigators [80], 
requiring universities to conduct routine audits of data collections in research departments [81], and 
establishing research certification institutions that conduct random audits of 1% of NIH-sponsored 
studies [78]. There has been little discussion of who would fund such initiatives, however. Academic 
grants rarely include enough funds to establish an audit program [77].  
Study Setting: CCASAnet 
All four components of this research address the implementation and effectiveness of data 
auditing in an international, multicenter observational research network for HIV. The project began in 
mid-2006 when the International Epidemiologic Databases to Evaluate AIDS (IeDEA) initiative, funded by 
the U.S. National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child 
Health and Human Development (NICHD), established seven regional research networks for the 
collection and harmonization of global data on the epidemiology and treatment of HIV. Four of the 
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sponsored networks were located in Africa (East, West, South, and Central), one in Asia, one in North 
America, and one in Latin American and the Caribbean. In addition, the initiative includes the 
establishment of an international research consortium. Through these data centers and consortium, 
researchers will address unique and evolving research questions in HIV/AIDS that individual cohorts are 
unable to address. 
The Caribbean, Central, and South America Network for HIV Epidemiology (CCASAnet) is one of 
the seven IeDEA regional collaborations and is the setting for all research reported here. The CCASAnet 
partnership combines the clinical and research expertise of investigators at seven HIV clinics in 
Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru with bioinformatics and biostatistics 
resources from Vanderbilt University in Nashville, Tennessee, USA.  The seven member countries are 
labeled on the map in Figure 2. 
 
Figure 2: Member countries of the Caribbean, Central, and South America network for HIV Epidemiology 
Countries participating in the CCASAnet consortium include Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and 
Peru.  
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Most CCASAnet sites are large, urban HIV clinics with associated academic or public hospitals 
that employ paper records for patient care. Clinic personnel transfer data from paper records into locally 
developed electronic databases for patient tracking and research. The names and locations of 
participating sites and the number of records in their research database are listed in Table 1. 
 
Table 1: Countries and clinics participating in the CCASAnet collaboration 
Sites in seven countries participate in the CCASAnet consortium. The numbers of records in each site’s dataset are 
current as of November 2010. 
CCASAnet
Site City Participating Clinics Records 
Argentina Buenos Aires Fundación Huésped, Hospital Fernández, Centro Médico Huésped 8400 
Brazil Rio de Janeiro Hospital Universitario Clementino Fraga Filho  600 
Chile Santiago Fundación Arriaran 2800 
Haiti Port-au-Prince GHESKIO 3700 
Honduras Tegucigalpa Instituto Hondureño de Seguridad Social, Hospital Escuela 900 
Mexico Mexico City Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran  400 
Peru Lima Instituto de Medicina Tropical Alexander von Humboldt 3400 
 
The CCASAnet collaboration encompasses six core objectives, to (1) develop a network of clinical 
sites in Latin America and the Caribbean, (2) assemble datasets from pooled routine care data from 
participating sites, for the purposes of answering questions that cannot be answered using datasets , 
from any single locale, (3) develop new biostatistical methods to handle such data, (4) conduct joint 
research projects that further the understanding of HIV and related diseases in the region, (5) work with 
sites to enhance their clinical research capacity, and (6) collaborate with other IeDEA regions on global 
projects in HIV research [82]. CCASAnet’s clinical studies to-date have explored mortality during the first 
year of antiretroviral therapy among HIV-infected patients in the region, reasons for therapy changes, 
cancer incidence in the cohort, reasons for late initiation of antiretroviral therapy, and recurrence of 
tuberculosis among HIV+ persons [83-86].  
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CCASAnet Audit Process 
Poor quality datasets could present significant difficulties for CCASAnet studies by preventing 
the identification of accurate subsets of patients for retrospective analyses, hampering the process of 
merging data from multiple sites, producing invalid conclusions from the research data, and making it 
unfeasible to compare results to findings in other settings. To identify problems with the reuse of 
routine patient care data, CCASAnet has instituted a process of periodic data monitoring visits at its 
member sites, using audit principles adapted from GCP guidelines. The CCASAnet Data Coordinating 
Center hosted at Vanderbilt University conducts project-driven audits when new datasets are submitted 
for proposed region-wide studies. Such audits help CCASAnet participants to identify sources of error in 
data collection, abstraction, and representation, and help the Data Coordinating Center (DCC) to 
determine the structure, quality, and reliability of the submitted data. The DCC also conducts a second 
round of supportive quality improvement-focused audits at sites where significant challenges to data 
capture and quality have been identified. 
The audit cycle begins when a CCASAnet site submits data to the coordinating center for a 
region-wide project. A team from the DCC visits each of the CCASAnet participating sites and compares 
the contents of the electronic database the site has submitted to the DCC to local source documents. 
The source documents available at CCASAnet sites are mainly paper clinical records, though some sites 
maintain electronic laboratory, pharmacy, and patient medical record systems. On the final audit day, 
the audit team meets with the site PI and describes the preliminary findings of the data monitoring visit. 
The group discusses the site’s data quality and the strengths and weaknesses of the current data 
collection approach. The audit team then presents an initial set of recommendations and discusses their 
feasibility with the local PI and data personnel. 
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After the audit team returns to the DCC, team members review the audit records, classify data 
errors, omissions, and inconsistencies, and tabulate the results by data category. They also compile 
comparison charts for individual records that present side-by-side the database and source document 
content, so local data personnel can see specific discrepancies. The audit team then composes a data 
audit report that contains the error tables and comparison charts and describes in detail audit findings 
and the DCC’s recommendations. The DCC consults with site data personnel to adapt and implement the 
recommendations detailed in the audit report and solicits feedback from the sites about the data audit 
process. CCASAnet data audit preparations and processes are described in greater detail in Chapters III 
and V. 
In summary, routine clinical care data, particularly data generated in resource-limited settings, is 
often of poor quality. Although such data can compromise clinical research findings, researchers rarely 
conduct extensive quality assessments, particularly when managing unregulated, observational studies. 
Auditing is an expensive but cost-effective method of determining the quality of research data. 
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CHAPTER III 
MEASURING THE QUALITY OF OBSERVATIONAL DATA IN AN HIV RESEARCH NETWORK  
Introduction 
Accurate and valid HIV research results depend on high-quality clinical and laboratory data. 
Excellent patient care itself depends on accurate recording and transcription of such information [87]. 
Interventional clinical trials, such as those generating data for pre-marketing approval by regulatory 
agencies or those conducted by the AIDS Clinical Trials Group [88], follow careful data quality assurance 
procedures. This ensures that investigators comply with the International Conference on 
Harmonization’s guidelines for Good Clinical Practice and that collected data reflect true measurements 
[1,89]. A data audit, in which an external review team compares a research dataset to the original data 
collection documents, is the standard method of assessing the quality of data in clinical trials 
[38,59,90,91]. 
Depending on the nature of the research question, researchers and funding agencies may use 
routine patient care data as a readily available and inexpensive supplement or alternative to data 
generated through prospective clinical trials [10,92]. Databases that pool such observational data from 
multiple, international sites have become particularly important resources for HIV/AIDS research due to 
increased interest in measuring global trends in the epidemic and the side effects and long-term 
outcomes of antiretroviral (ARV) therapy [11,93-96]. Routine medical care data, however, do not 
undergo the same stringent quality controls commonly applied in clinical trials. International multi-
center HIV networks that use routine patient care data may be at higher risk of having data quality 
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issues because monitoring for quality at geographically distant locations is difficult, time-consuming, and 
expensive.  
Many networks that repurpose routine medical care data for research rely on data cleaning and 
cross-referencing performed at the data coordinating center [40]. These techniques can confirm the 
data’s internal consistency and identify missing values but cannot determine data accuracy and 
authenticity. Comparing research data to their source documents through audits is therefore an 
essential additional step in verifying the data’s accuracy [97]. Despite the importance of using high-
quality data, no multi-center observational HIV cohort has published research indicating that they 
conducted frequent source-to-database data comparisons. As a result, the quality of data and the 
accuracy of results from many multi-site HIV cohorts can be uncertain. 
We evaluated the accuracy and completeness, as assessed by on-site data audits, of routine 
patient care data submitted for research by seven sites participating in CCASAnet.   
Methods 
Study Setting 
The audits took place at all seven CCASAnet sites in Argentina, Brazil, Chile, Haiti, Honduras, 
Mexico, and Peru. To preserve the anonymity of the participating clinics, we have labeled them 
randomly as sites A-G. 
All seven CCASAnet sites used paper medical records as the primary means of storing patient 
information. The paper clinical records generally contained a structured patient intake form followed by 
handwritten visit notes. Nursing staff at sites F and G maintained detailed drug dispensing forms that 
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were kept with the patient chart and used to verify drug prescriptions and dates. The different data 
collection practices and resources at each audit site are detailed in Table 2. 
 
Table 2: Characteristics of data abstraction and management at audit sites A-G 
A plus sign (“+”) indicates that the site employed such personnel or used such a form, system, or database. A 
minus sign (“−”) indicates the site did not display the listed characteristic. 
 Sites 
 A B C D E F G 
Structured visit form + − − − − − − 
Drug dispensing form − − − − − + + 
Electronic laboratory system − + − − − + − 
Locally developed and maintained database + + + + − + + 
Data manager + + + + − − + 
Full-time data abstraction team − − − + − − + 
Internal data audits − − − − − + − 
 
 
At all sites, a team of clinicians, data entry personnel, or administrative staff abstracted 
information from the paper medical record and entered the results into an electronic research database 
from which data were extracted for CCASAnet studies. Sites B and F had access to electronic laboratory 
systems that exported test results directly into their research databases. The majority of these 
databases were designed and maintained by local staff and implemented in Microsoft Access. One site 
used a commercial data warehousing service in place of an on-site database server. Two of the seven 
sites employed experienced data managers (B, C); three of the remaining sites had data managers 
without formal training (A, D, G.) Only Site C operated an extensive data center. Site F was the only site 
that actively conducted internal quality reviews of their research data. 
Institutional Review Board approval was obtained locally for each participating site and for the 
DCC. Local centers de-identified all data before transmitting it to the DCC. 
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Data Audit Preparation and Process 
Between April 2007 and March 2008, a team from the DCC -- including at least one HIV clinician 
and one informaticist -- conducted on-location audits of the datasets received from CCASAnet member 
sites. Our audit techniques involved verifying data integrity using source documents and were adapted 
from those used in clinical trials to ensure Good Clinical Practice (GCP) compliance [70].  
The DCC data manager selected approximately 30 records at random from the database 
submitted by each participating site. We sent research identification numbers (IDs) for 20 records to the 
site ten days before the data monitoring visit to allow local data personnel to retrieve the records in 
advance. We requested the remaining ten records from the site investigators on the first audit day. 
Our initial audits lasted two to three days per site. Sites for which we recommended major 
quality interventions were re-audited during the current or subsequent audit cycle. During each audit, 
we compared the contents of the study database to the local source documents and noted 
discrepancies and inconsistencies in individual data elements. The available source documents included 
paper clinical records and, where available, electronic laboratory, pharmacy, and medical record 
reports. We reviewed as many source documents as the sites could locate during the visit and consulted 
local site personnel for clarifications as needed. Audit findings were recorded on a structured paper 
audit form and later entered into an Excel spreadsheet for analysis. 
The audited variables included those most relevant to proposed consortium studies: patient 
demographics, HIV-related risk factors, weight measurements, CD4+ lymphocyte (CD4) counts, plasma 
HIV-1 RNA levels (viral load), all ARV regimens, and all dates associated with each measurement. When 
an individual ARV regimen was recorded as “current” or “ongoing” in the database, we verified that the 
patient was still taking the specified drug combination at around time the site data were submitted to 
the DCC.  
  22 
 
Error Classification 
After each audit, we reviewed the completed paper audit forms and categorized audit results 
using standardized audit codes from the European Organization for the Research and Treatment of 
Cancer (EORTC) [38]. The audit data were labeled correct (code 1) if the database values submitted to 
the DCC matched the values in the paper clinical record or other on-site source documents. Major errors 
(code 3) represented discrepancies between the clinical record and database values that the physician 
on the audit team deemed clinically meaningful. Other discrepancies were labeled minor errors (code 2, 
e.g., weight values rounded to the nearest integer, dates in the database within six days of the 
documented date). Missing/missed data (code 4) included values for requested information (e.g., 
baseline weight) that auditors found in the clinical record but had been left blank in the database. 
Values that existed in the submitted database but not in the clinical record were labeled sourceless 
(code 5). One auditor performed the initial classification, a second auditor reviewed all classifications, 
and all disagreements were resolved by joint record review. A coded sample record is presented in Table 
13 and Table 14 of Appendix A. 
Statistical Analysis 
We calculated error rates by dividing the number of erroneous clinical record/database value 
pairs (codes 3, 4, and 5) by the number of audited value pairs. We compared error rates across variables 
using a generalized linear mixed model to account for correlations between variables from the same 
record and within the same clinic. Analyses comparing major error rates (code 3) between variables did 
not include missing or sourceless errors (codes 4 and 5) in the denominator. 
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 Results 
Record Availability 
We requested a total of 208 randomly selected patient records during seven data audits at Sites 
A-G. Of these 208 records, 16 could not be located or were unavailable because they were needed for 
patient care. The majority of missing records (11 of 16) were from Site A. We reviewed 184 of the 
remaining 192 charts (eight charts were not audited because of time constraints) comprising 4,223 
unique data points. The number of unavailable, available, and audited charts by site is shown in Table 3. 
Table 3: Availability of randomly selected clinical records requested by the audit team according to site 
Audit Site 
Total charts 
requested 
Charts available 
and audited 
Charts available 
but not audited 
Charts 
unavailable 
A 40 29 0 11 
B 28 23 3 2 
C 17 17 0 0 
D 28 27 0 1 
E 33 27 5 1 
F 35 35 0 0 
G 27 26 0 1 
Total 208 184 8 16 
Error Rates 
 
The dataset of all audit results contained 3,581 correct data points, 66 minor errors, 171 major 
errors, 274 missing values, and 131 sourceless values. Minor errors – which were not counted towards 
error rates – included dates that were shifted by a few days (45%), inappropriately rounded weight 
measurements (36%), and weight, CD4, and viral load values where a probable typographical slip 
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resulted in small value differences (19%). Table 4 shows the number of variables audited at each site 
and their specific error rates. 
 
Table 4: Total number of audited variables and percentage of erroneous data by variable type during initial 
CCASAnet audits at seven sites. 
This table shows the number of variables audited in each of eleven categories of data, including gender, birth date, 
weight, CD4 count, viral load, antiretroviral (ARV) regimens, and all associated dates. 
 Audit Sites
a
 
 A B C D E F G All 
 N %err N %err N %err N %err N %err N %err N %err N %err 
Variables                 
  Gender 29 0% 23 0% 17 0% 27 0% 27 0% 35 0% 26 0% 184 0% 
  Birth date 29 7% 23 9% 17 0% 27 19% 27 0% 35 0% 26 0% 184 5% 
  Weight 29 31% 37 41% 55 11% 26 38% 27 93% 268 1% 45 2% 487 14% 
  Weight date 29 21% 37 30% 55 15% 26 38% 27 100% 268 0% 45 9% 487 14% 
Laboratory data              
CD4 29 14% 33 21% 31 6% 96 13% 132 5% 134 1% 88 5% 543 7% 
CD4 date 29 21% 33 27% 31 10% 96 16% 132 17% 134 1% 88 8% 543 12% 
Viral load
b
 29 7% 26 42% 0 -- 57 25% 120 7% 112 1% 84 4% 428 9% 
Viral load date
b
 29 17% 26 42% 0 -- 57 28% 119 13% 112 0% 84 7% 427 12% 
Antiretroviral regimen data              
Regimen 46 11% 54 26% 23 13% 38 21% 49 22% 67 7% 47 19% 324 17% 
Start date 46 28% 54 56% 23 13% 38 32% 49 39% 67 12% 47 26% 324 30% 
Stop date 30 27% 54 50% 7 29% 38 29% 49 33% 67 10% 47 38% 292 30% 
All 354 17% 400 34% 259 10% 526 21% 758 20% 1299 2% 627 10% 4223 14% 
a
Columns contain the counts for each site (N), along with the percentage of data that was labeled “in error” by auditors (%err). The reported 
percentage of erroneous data includes incorrect, missing, and sourceless values (error categories 3, 4, and 5), but not minor errors. 
b
Site C did not submit any viral load data. 
 
All audited instances of patient gender were correct, and all birth dates were correct at four of 
seven sites. At the remaining three sites, 7-19% of the birth dates recorded in the site database differed 
by a week or more from values in the clinical record. Weight values and their associated dates were 
entered in the database with few or no errors at Sites F and G. Error rates at the remaining sites ranged 
from 11-93% for weight measurements and 15-100% for weight dates.  
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Figure 3: Breakdown of error rates by error type for birthdate, gender, weight, and weight date variables from 
audit sites A-G.  
Values are shown with bars representing 95% confidence intervals.  A gray line marks a 10% error rate. 
At the three sites with the highest error rates, weight data missing from the database were the primary 
cause of error (24-89% missing weight measurements and 24-100% missing weight dates). The data 
error rates due to incorrect, missing, and sourceless data for birthdate, gender, and weight variables are 
depicted in Figure 3. 
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Figure 4: Breakdown of error rates by error type for CD4 and viral load-related values from audit sites A-G.  
Values are shown with bars representing 95% confidence intervals. A 10% error rate is indicated with a gray line. 
Sites varied less in error rates for laboratory values: CD4 count (1-21%), CD4 dates (1-27%), viral 
load (1-42%), and viral load dates (0-42%). For CD4-related values, the dominant error type varied by 
site. Site A’s CD4-related errors primarily were due to incorrect information, Site B’s errors to missing 
values, and errors at Sites E and F to data without source documents. For viral load measurements and 
dates, Sites B and D presented the highest error rates, primarily due to missing information. The 
composition of error rates is depicted in Figure 4. For the records with major errors (code 3) in 
laboratory data, the median and interquartile range (IQR) for absolute differences between the 
database and chart values were 20 cells/mm3 (9-101 cells/mm3) for CD4 count, 23 days (10-56 days) for 
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CD4 date, 65,200 copies/ml (47,000-145,600 copies/ml) for viral load, and 22 days (11.5-50 days) for 
viral load dates.  
Errors in antiretroviral data according to audit site and error type (and their 95% confidence 
intervals) are shown in Figure 5. For 7-26% of ARV regimens, the drug combinations were missing from 
the site’s submitted database, incorrectly entered into the database, or not substantiated by content in 
the clinical record. All sites had overlooked several old and intermittent drug regimens when abstracting 
patients’ treatment histories for the datasets submitted to the DCC. Such missing data were least 
frequent at Sites D and F. 
 
Figure 5: Composition of error rates for antiretroviral regimen data from audit sites A-G.  
Values are shown with bars representing 95% confidence intervals. A 10% error rate is indicated with a gray line. 
The start and stop dates of antiretroviral regimens appeared to have higher error rates than the 
regimens themselves, with rates ranging from 10-56%. Figure 6 depicts rates of erroneous ARV dates, 
which were in excess of 10% at most sites. There was no difference in error rates when comparing 
stopping and starting dates (P >0.25 for both major errors alone and overall errors.) For records with 
major errors (code 3), the median absolute difference between start/stop dates found in the chart and 
those recorded in the database was 88 days (IQR: 31 – 365 days). 
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Figure 6: Composition of error rates for antiretroviral regimen start and stop dates from audit sites A-G.  
Values are shown with bars representing 95% confidence intervals. A 10% error rate is indicated with a gray line. 
 Overall, the error rates for ARV regimen start and stop dates were higher than the error rates 
for all other non-ARV dates, including the dates of weight, CD4 count, and viral load measurements (P 
<0.001 for all.) For CD4 count, viral load, and ARV data, the associated dates had a higher rate of major 
errors (category 3) than the actual values (P <0.001 for all sites), whereas weight values had more major 
errors than weight dates (P = 0.028 for all sites). 
Re-Auditing of Sites 
After the findings of the initial audit, Site B cleaned and reabstracted their study data and 
quickly submitted an updated version, allowing us to reaudit the site at the end of the initial audit cycle. 
We reviewed 26 randomly selected records with 463 variables during this second audit at Site B; four 
additional records we requested were not available during the audit period. We observed reduced error 
rates in all variable categories. The overall error rate dropped from 34% to 17% (Table 5). 
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Table 5: Variable counts and error rates by data category during initial and follow-up audits at Site B 
 Initial 
Site Audit 
Follow-up Site 
Audit 
 N %err N %err 
Variables     
Gender 23 0% 26 0% 
Birth date 23 9% 26 8% 
Weight 37 41% 42 26% 
Weight date 37 30% 42 21% 
Laboratory data     
CD4 33 21% 35 6% 
CD4 date 33 27% 35 6% 
Viral load 26 42% 32 16% 
Viral load date 26 42% 32 13% 
Antiretroviral regimen data   
Regimen 54 26% 65 12% 
Start date 54 56% 64 23% 
Stop date 54 50% 64 33% 
All 400 34% 463 17% 
Discussion 
Summary of Findings 
Our data audits revealed substantial error rates in data submitted by all seven participating 
clinics. The majority of errors were due to measurements found in clinical records that were not entered 
into the database, laboratory values with no source documents, and incorrect antiretroviral regimens. 
Dates were especially prone to error, and sites had the most difficulty accurately capturing antiretroviral 
drug regimens and their associated dates. Most sites had error rates above 10% for ARV regimens and 
dates. These findings would trigger strict quality interventions in prospective clinical trials, which 
typically require fewer than 50 errors per 10,000 fields (<0.5% error rate) [49]. In the context of clinical 
trials, however, source-to-database audits like those described here generally report similarly high error 
rates when compared to case-report-form-to-database audits [45]. 
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We found that data inconsistencies resulted from how the sites recorded information in the 
clinical record, how they abstracted data for research, and how they entered, stored, and formatted the 
data in the electronic database. Many laboratory dates could not be confirmed because the original 
laboratory reports had been discarded, a common practice due to lack of storage space. Errors in ARV 
data often resulted from haphazard data abstraction from paper records used for clinical care. Sites that 
used rotating personnel for data abstraction, such as care providers, medical students, residents, and 
other trainees, appeared to have higher rates of ARV data errors compared with those that assembled 
focused and well-trained teams. Error rates did not appear to be associated with the level of experience 
of the local data management team or with the presence of a data center. We currently are performing 
additional studies to better understand reasons for data inconsistencies. 
The audit functioned as a useful data quality control for both the data coordinating center and 
the participating sites. It allowed the DCC to identify and resolve weaknesses in submitted data before 
erroneous data could affect study results and provided sites with a baseline estimate of their data 
quality. As a result, all published CCASAnet studies use revised site data. 
Recommendations 
The findings prompted us to recommend many of the same quality improvement interventions 
for each site:  
 
 Standardize data abstraction, database entry procedures, and personnel training to 
reduce variability in data quality. The audit team observed avoidable errors like 
improperly selected laboratory dates (laboratory results should be paired with the date 
the sample was drawn rather than the date it was processed or the date of the finalized 
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laboratory report) and rounded weight values (i.e. 56.7 kg rounded to 56 kg) that led to 
overall information loss. Such systematic errors could be prevented by educating data 
abstractors to follow consistent rules during data collection and entry. 
 Develop structured patient visit forms, either paper or electronic, to encourage 
consistent provider documentation and reduce the amount of missing information. Our 
audits determined that the majority of weight-related errors from three sites were due 
to missing weight measurements. By replacing the blank sheets of paper these sites 
used for clinician notes with a printed form that prompted providers to record patient 
weight in a field, some of these missing values could be prevented. 
 Retain laboratory reports whenever possible to reduce the number of sourceless, 
unverifiable laboratory values and dates. Sites D, E, and G did not routinely keep copies 
of the original laboratory reports in the patient medical record, resulting in code 5 
errors for associated values (sourceless data). The audit team compared the study data 
to handwritten laboratory flowsheets when possible, but these were not true source 
documents. 
 Revise the procedure for storing dates in the database so that data abstractors can 
accurately record dates that are only known to month or year precision. We noted that 
ambiguous dates in the patient record resulted in frequent date-related errors in ARV 
information. 
Each site positively accepted the feedback and submitted a data quality improvement plan to 
the DCC. We have not yet formally studied the impact of these quality improvement interventions, but 
early results suggest that the audit process has led to improved site procedures. Our first follow-up audit 
found a 50% decrease in the overall error rate, with most of the remaining errors resulting from missing 
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data (values that existed in the clinical chart but were not entered in the database) rather than incorrect 
information. 
Limitations 
Our study had both strengths and weaknesses. The analysis of audit findings used a 
straightforward error categorization system that required little subjective interpretation, making these 
findings easy to replicate. Our multi-lingual auditors were confident reviewing medical records in 
French, Spanish, and Portuguese, and their training allowed them to identify causes of error related to 
clinical process and data handling. Potential variation was minimized by using the same core audit team 
during every visit. However, the audit team could inspect only a fraction of records at each site, so 
although records were randomly selected for auditing, the true error rates may differ from the 
estimated rates reported here. Furthermore, the audit process evolved as the team gained experience 
with each successive audit, so audits performed later may have been more likely to uncover errors.  
Conclusion 
Routine clinical care records are a valuable source of diverse, plentiful, and relatively 
inexpensive medical data for HIV/AIDS research. Without quality control, however, these data may not 
be sufficiently complete or reliable for research. Investigators who reuse clinical care data must be 
proactive in addressing potential quality concerns. We do not suspect that the error rates observed in 
our cohort are substantially higher than those that would be seen if source-to-database audits were 
performed in other multi-center HIV cohorts. Indeed, several of our sites have participated in other 
multi-site cohorts such as ART-LINC, TCHARI, and CHIAC [11,98,99]. We do not claim that the findings of 
other multi-center observational HIV cohorts are erroneous, but it is difficult to interpret study validity 
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without a formal assessment of data quality. Collaborative research networks – especially those in 
international settings – should strongly consider implementing formal audit programs to evaluate the 
reliability of their data sources, to correct discrepancies in data that have already been collected, and to 
prevent errors in prospective data collection. 
On-location audits require often-scarce resources. In order to minimize costs, many of our 
audits were performed during visits with other scientific objectives. We are currently developing an 
electronic audit support tool to help standardize and simplify the audit process, allowing auditors to 
import an electronic dataset, select a set of records to audit, document their findings in real-time using a 
pre-defined error taxonomy, and quickly generate summaries of audit results. We also are exploring the 
possibility of incorporating data quality self-assessments as a formal component of our data quality 
control procedures.  With such an approach, sites can perform self-assessments of data quality, which 
may permit the DCC to reduce the frequency of external audits.  Under certain conditions, audit results 
can be used to statistically adjust estimates based on the original, error-containing data [100]. A data 
audit should be viewed as an important tool for improving the quality of data, the validity of associated 
study results, and the reliability of future data collection procedures.   
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CHAPTER IV 
INVESTIGATING PERCEIVED REASONS FOR DATA QUALITY VARIATIONS 
Introduction 
Meaningful clinical research results derive from complete, accurate, and reproducible study 
data. In highly regulated biomedical research like interventional clinical trials, the quality of such 
datasets is assessed routinely through source document verification [52,90]. These audits verify a 
study’s compliance with Good Clinical Practice (GCP) standards and produce quantifiable measures of 
the accuracy and completeness of research data [1]. Unfortunately audits conducted after data 
collection is complete often focus on numerical estimates of the error rates in finalized datasets, which 
rarely leads to a deep exploration of the factors contributing to error [90].  
Source verification data audits play an important role in CCASAnet. Between April 2007 and 
March 2008, members of the network’s data coordination center (DCC) visited CCASAnet sites to 
conduct source verification audits of data submitted for two studies of outcomes in HIV-positive, 
antiretroviral treatment-naïve persons. The DCC adapted audit techniques and error coding systems 
used to ensure GCP compliance in controlled clinical trials conducted by the European Organization for 
Research and Treatment of (EORTC)[101]. 
During the audit, auditors from the DCC recorded errors of three types: (1) measurements in the 
submitted research data that did not exist in the clinical record, (2) research data that conflicted with 
clinical notes, and (3) significant content in the clinical record that was not included in the research 
dataset. After the audit, team members reviewed the audit findings, classified the errors, omissions, and 
inconsistencies, and calculated error rates by data category. Auditors calculated an overall error rate per 
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site, an error rate for each variable type such as patient weight or CD4+ lymphocyte count (CD4), and 
percentages of incorrect, missing, and unverifiable data.  
Such audits provided detailed numerical estimates of the data quality at each site, as described 
in Chapter III, but were not designed to investigate the causes of observed errors, particularly in 
variables that proved to have high error rates, such as laboratory data, weight measurements, and 
antiretroviral data. We decided to revisit the patterns of error detected during on-site audits by 
surveying site personnel about the perceived reasons for errors in the research data. This study 
investigated the causes of data quality differences across the sites through an analysis of responses to 
both general and site-specific survey questions.  
Methods 
Subjects and Settings 
The study population included all employees and volunteers who were responsible for 
developing, creating, and maintaining sources of data at CCASAnet member sites. Potential participants 
were identified by local project coordinators and included physicians, nurses, pharmacists, research 
directors, data managers, and data entry personnel. Our target sample included at least three 
participants from each site and 21 or more people in total, though we encouraged local site 
coordinators to involve as many personnel as had worked on the CCASAnet datasets. The study 
investigators were blinded to the identities of the survey respondents since the site coordinators, not 
the study investigators, identified potential participants. The Vanderbilt Institutional Review Board 
approved the study.  
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Survey Design 
We developed a multi-part survey that included general questions about the participating site 
and its data collection practices, and site-specific questions based on quantitative results from the on-
site audits. All multiple choice questions were in English, but study participants were encouraged to 
complete the free text portion of the survey in the language in which they felt most comfortable. The 
survey questions did not solicit person-identifying information. Participants were asked to identify the 
country their site was located in, but not their workplace or role in the organization.  
The site-specific questions focused on three classes of data: weights, laboratory results including 
HIV viral load, CD4, and hemoglobin (where available), and antiretroviral drug regimens. Sites with error 
rates greater than 10% in any of these variables, according to the preliminary results of the cross-site 
audit comparison, were asked to describe potential causes of error. The survey included additional, 
targeted questions if the majority of errors were due to incorrect information, missing source 
documents, or data that existed in the clinical record but were not included in the study dataset. Sites 
with error rates less than 5% in any data category were asked to describe what data collection processes 
they employed to produce better quality results. Table 6 shows which specialized questions were posed 
to which sites. Sites are labeled A-G to preserve anonymity. 
Each question set was implemented in REDCap Survey, a secure, web-based application 
designed to support research data capture [102]. A link to the custom survey was e-mailed to 
coordinators at each CCASAnet site, who encouraged individuals involved with the data collection and 
preparation to complete the survey. We invited study subjects who completed the survey for a free 
raffle to win one of two iPod Shuffles. Participation in the iPod raffle was optional and entries were not 
associated with survey responses. We sent two follow-up, reminder emails about the quality survey to 
coordinators at each site. The survey was distributed in March 2009 and closed in June 2009. 
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Table 6: Questions included in data quality surveys administered to sites A-G 
 
Sites 
Topics of survey questions A B C D E F G 
Why are weight values… 
       correct  
     
x x 
incorrect  x 
      missing  
 
x 
 
x x 
  Why are laboratory measurements… 
     correct  
 
x x 
 
x x 
 incorrect  x 
      missing  
 
x x 
    without source documents 
   
x 
  
x 
Why are antiretroviral drugs/dates… 
correct  
  
x x 
 
x 
 incorrect x x 
  
x 
 
x 
missing 
 
x 
  
x 
 
x 
Data Analysis 
We exported the survey results from REDCap in comma-separated-values format and tabulated 
multiple choice answers in Excel. Two researchers separately reviewed the free text responses for 
potential themes. We selected key recurrent themes through iterative analysis and group discussion of 
our findings. Responses were analyzed in the language in which they were written. For this narrative, 
the researchers produced translations that were reviewed by fluent speakers. Responses in English by 
non-native speakers were edited for correct spelling and basic grammar where necessary. 
Results 
The DCC received eighteen completed surveys, representing six of the seven HIV clinics 
participating in CCASAnet. Site F never responded to our requests to participate. During the survey 
period, Site D was employing only two individuals who had been involved with data collection and 
processing for CCASAnet and therefore could not meet the target of three participants per site. Site A 
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also submitted only two surveys. We received three to four completed surveys from the remaining sites. 
The survey response rate, given a target of three responses per site, was 16/21 surveys (76%). 
General Questions 
Survey participants at two-thirds of the sites reported three to five clinical and data 
management personnel collected the research data that were submitted to CCASAnet. Data gathering 
teams were larger at Site B (6-8 people) and Site G (8-10 people.) At all sites except Site E, the majority 
of on-site data abstraction personnel were clinicians, particularly doctors and nurses, rather than data 
entry personnel. All sites had data managers or data entry personnel who entered data into the 
database. The reported characteristics of each site’s data abstraction and data entry teams are listed in 
Table 7 and Table 8. 
 
Table 7: Groups involved in data abstraction, as reported by sites A-E, G 
This table displays responses to the survey question, "at your site, what groups collect research information from 
clinical records?” The number of responses in each category from sites A-E, G, is indicated in the table cell.  
Personnel involved in abstracting 
data from medical records 
# responses at Site 
A B C D E G 
Doctors 2 4 2 
 
2 3 
Nurses 
 
4 2 2 
 
2 
Personnel hired for data entry 
  
1 
 
4 
 Data managers 1 
 
2 
  
1 
Clinic administrators 
      Medical students 
  
1 
   Pharmacists 
  
1 
   Other 
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Table 8: Groups involved in research data entry, as reported by sites A-E, G 
This table displays responses to the survey question, "at your site, what groups enter information into the 
database?" The number of responses in each category from sites A-E, G, is indicated in the table cell.  
Personnel involved in entering data 
into the research database 
# responses at Site 
A B C D E G 
Doctors 
  
3 
 
1 
 Nurses 
  
3 
  
2 
Personnel hired for data entry 2 
 
1 
 
4 3 
Data managers 1 3 3 2 
 
1 
Clinic administrators 
      Medical students 
  
1 
   Pharmacists 1 
 
3 
   Other 
 
1 2 
   
Weight Measurements and Dates 
We surveyed four of six sites about causes for incorrect or missing patient weight data.  All 
survey participants at three sites indicated their clinics did not measure weight during every patient 
visit, particularly for “patients who attend regularly and don’t have clinical changes.” However, the 
reasons why clinicians did not assess weight varied by site. Respondents from Site E noted that clinicians 
“do not judge *weight to be+ an important measurement.” Furthermore, at this site, weight was a 
culturally sensitive topic and “was not considered a key variable for… studies.” The structure of the site’s 
research database reflected the perceived unimportance of this measurement, as there was only “a 
place to enter baseline weight but not other weights.”  
In contrast, patient weight at Site B was not assessed routinely because the clinic had no reliable 
scales. There was “a lack of material resources -- many broken scales, all in disrepair, and only a few of 
them (one scale for more than 20 outpatient departments.)” The participant noted that “this makes the 
practice of measurement infrequent or even discredited, as it is not possible to rely on the 
anthropometric instrument in question.” Respondents from Site A speculated that weights were 
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measured but never recorded in the clinical record, while participants from Site D were unsure why the 
data were missing. 
The remaining two sites (C, G) captured accurate weight data for ≥95% of cases. One participant 
described measuring and recording weight as an essential part of the patient visit: “In each medical 
encounter during the admission of the patient, a paramedic is charged with measuring the current 
weight, blood pressure, and pulse pressure, and recording those in the clinic file.” They also described 
having multiple opportunities to capture the same data. If the nurse failed to measure weight during 
intake, “it is recorded at the same time as the physical examination, by the doctor.” This form of 
redundant data capture was also effective at reducing the frequency of errors and missing data at site C, 
where weight measurements were recorded in the chart and also entered in “real time *in+to the 
electronic medical record (EMR) at each clinic visit.” 
Laboratory Results and Dates 
We queried five sites about problems with laboratory data quality, primarily missing source 
documents and missing CD4, viral load, and hemoglobin laboratory measurements and dates. When 
laboratory values such as baseline viral loads were missing, it was often because the site lacked the 
resources to request the test (Site C) or clinicians displayed a preference for clinical diagnosis of 
“patients presenting for care at advanced stages of disease.” or “laboratory problems that severely 
*delayed+ the result.” (Site B) 
One of the greatest concerns during the audit was that many sites submitted extensive lab test 
results for patients in their research dataset, but the audit team could not find corresponding 
information in the clinical records. At two sites, D and G, over 10% of laboratory values had no source 
document. Respondents noted that “paper laboratory slips are easy to lose,” but described different 
  41 
 
factors that contributed to missing source documents at each site. At Site D, laboratory results were 
“most often provided in the form of lists,” which could be large paper packets that were difficult to 
attach to the medical record. As a result of the printed format, laboratory documents were “not 
routinely included in the file,” leaving clinicians responsible for transcribing information “from the lab 
slip into the medical record.” At Site G, on the other hand, laboratory results were recorded on small 
paper slips and the primary cause of missing source documents was a lack of shelf space in the record 
room and “lack of space in the file.” In response to space concerns at site G, “the test results are 
transcribed into the clinical file (onto the summary sheet for tests) and the laboratory reports are 
eliminated.” Failure to transcribe the data before disposing of the source document resulted in 
additional missing information. “We don’t have space to keep all laboratory slips,” wrote one 
participant, and “if the patient wants the lab printout we give it to them.”  
However, laboratory data had the lowest overall error rates of any data category on the survey. 
Such data were rarely incorrect except at Site A, where a typographical error resulted in several 
database records being paired with incorrect lab values during data export. The attitude of many sites 
towards CD4 and viral load (VL) results was very different than weights. “Doctors considered these 
data… important for patient care.” Follow-up visit forms often had a “special place to enter CD4 and VL” 
to promote structured data capture. The research database maintained by Site B received direct data 
exports from the laboratory system.  
Antiretroviral Regimens and Dates 
The GCP audits revealed that most sites faced difficulties collecting complete and accurate 
pharmacy data. The survey queried four sites with error rates >10% about reasons for quality concerns 
with antiretroviral regimens and dates. The three sites with missing medication data agreed that “data 
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abstractors sometimes miss old or short ARV regimens” and old treatments at other clinics or “with one 
or two drugs instead of full HAART” were easily overlooked during data abstraction (Sites B, E, G). Site G 
also noted that because of insufficient data personnel, “updating the database is not a fast enough 
process to keep the data up to date.”  
Respondents from all four sites explained that regular delays between the dates when a 
physician prescribes treatment, the government approves the treatment, and the pharmacy dispenses 
the drugs result in multiple, conflicting dates that are recorded in the patient chart, and data abstractors 
are often unaware which one to use. At Site E, there is “lag time between prescription date (as written 
in the clinical record) and the actual provision *of medications+ by the federal government” and at Site 
G, there is a “gap between the prescription of the therapy, the petitioning of the ministry of health for 
the change, and finally the authorization of the change.”  
The two participating sites with <5% error in ARV data pointed to collaborative work with their 
local clinic pharmacies as a reason for higher quality. Both sites benefitted from having access to 
pharmacy records as a secondary source of information. At Site D, “this information is duplicated, is in 
the files and the database of the pharmacy.” Similarly, the “history of change in regimen *at Site C+ is 
kept at three places: the physician EMR [electronic medical record], the pharmacy EMR, the paper 
chart,” providing additional sources of information that helped reduce the number of missing and 
incorrect values. Unfortunately, Site B’s ARV data quality was tainted by pharmacy data that stored 
incomplete histories of patient medications: there was another source of ARV data (pharmacy), which 
did not have a log of regimen changes.” Sites whose ARV data was imported from a reliable pharmacy 
system had fewer medication errors. At Site C, “regimen records are entered directly into our database 
by Pharmacy personnel.”  
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Discussion 
According to the audit findings, every participating site encountered difficulties in collecting 
complete and accurate research data in one or more of the three categories: weight, laboratory, and 
pharmacy data. The responses of survey participants revealed that different categories of data have 
errors for different reasons. Weight data were often missing because clinicians assessed patient weight 
inconsistently, but the causes for infrequent measurements ranged from provider perception of the 
importance of weight measurements to broken scales. Auditors flagged many laboratory values because 
of absent source documentation, but responses revealed different reasons at affected sites, including 
oversized laboratory printouts, a lack of shelf space in the record room, and the practice of giving lab 
reports to patients.  
This survey-based approach generated diverse responses from site personnel; however the 
written format may not have elicited the greatest detail and variety in responses. Indeed, the audit team 
reported hearing of other reasons for error that were not mentioned by survey respondents, such as 
hospital records archives that were reluctant to release records for research, or hired medical students 
who produced patchwork data abstraction of multi-volume records. Clinicians and data management 
staff might have been more likely to divulge such information during spoken, face-to-face interviews. 
The survey provided insights into approaches to potentially reduce errors in research data 
abstracted from patient care records. It may be possible to avoid errors in weight data if there are 
multiple opportunities to measure weight during the patient visit and this measurement is made a clinic 
routine; in laboratory data, if lab slips are kept with the patient record, not discarded or data are 
imported directly from the laboratory system; and in ARV data, if data are compared to pharmacy 
records during data abstraction. However, there is no single data collection method or form capable of 
resolving all inconsistencies in data quality: the causes of erroneous data are related to both the nature 
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of the data and the culture of the workplace. By understanding the specific barriers to complete and 
accurate data collection in different settings, we may be able to effect more rapid, customized, and 
culturally appropriate changes that improve the reuse of routine patient care data for research. 
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CHAPTER V 
DEVELOPING A COMPUTER-ASSISTED TOOL FOR SOURCE VERIFICATION DATA AUDITS 
Introduction 
Source verification audits are the gold standard for assessing data quality in clinical research 
[103]. During such audits, external auditors compare research data to the original documentation of 
patient care, which may include paper clinical charts, laboratory reports, or the contents of electronic 
medical record and laboratory systems at the study sites.  Protocol-driven studies such as clinical trials 
often engage teams of clinicians and data managers to perform such audits, to ensure the study 
generates accurate results and follows best practice guidelines required by the U.S. Food and Drug 
Administration.  
Unfortunately, most verification audits of clinical data use paper forms, which have been shown 
in general to be less effective and efficient than electronic tools [104,105]. Examples of such forms are 
available online and in audit review books; many are simple grids, with no pre-printed elements from 
the database and only one column per record [67,106,107]. In such forms, auditors have no space to 
take notes or record corrected values; they only mark each data element as “satisfactory” or 
“unsatisfactory”.  
Although such paper-based audits are still common in medicine, computer-assisted audit tools 
(CAATs) have improved the quality of audits in finance, manufacturing, and network security by 
facilitating more thorough audits, generating more consistent documentation, and saving both time and 
money for auditors and auditees [108-110]. Specialized CAAT software can aid auditors during many 
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stages of the audit process, including selecting an audit sample size and methodology, merging and 
analyzing data, and generating audit reports. 
Financial audit software dominates the CAAT market. By the end of the 20th century, virtually 
every accounting firm conducted audits using commercial analysis suites (e.g., Audit Command 
Language (ACL) and Interactive Data Extraction and Analysis (IDEA)) or similar proprietary software 
[111]. Such CAATs assist auditors in downloading data from clients’ accounting databases, selecting the 
audit sample size and audit methodology, conducting cross-database comparisons, and detecting 
outlying, duplicate or potentially fraudulent transactions [112,113]. The software also provides user 
support based on guidelines and standards published by professional auditing societies, including the 
Financial Accounting Standards Board and the American Institute of Certified Public Accountants 
[108,114,115]. Each single-user ACL or IDEA license provides access to powerful data analysis tools, but 
also costs thousands of dollars. Less expensive audit-specific software includes TopCAATs, a Microsoft 
Excel audit plug-in, and Picalo, a Python-based, open-source data analysis and fraud detection toolkit 
[116,117]. Auditors also use statistical or data extraction software as a CAAT in order to detect 
anomalous patterns in large datasets. Most multi-purpose CAATs require computer programming skills.  
Some CAATs have been developed to assess quality in healthcare. UMTAudit, a large 
commercial audit suite, handles customized inspections in any industry but can be configured for 
medical compliance reviews, hospital accreditation audits, and adverse drug event investigations. The 
application allows auditors to assemble lists of questions to ask site personnel and supports the use of 
handheld devices for recording information and taking photos during walk-through inspections [118]. 
The Global Fund to Fight AIDS, TB, and Malaria distributes a different type of CAAT for measuring the 
quality of aggregate data reported to national health programs and donor-sponsored projects [119,120]. 
These form sets are available as Excel worksheets, named the Data Quality Assessment (DQA) for 
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external site inspections and the Routine Data Quality Assessment (RDQA) for internal assessments of 
program-level quality indicators. Both worksheets require users to input numeric results of data quality 
audits, but do not provide tools to conduct actual data validation against source documentation. A third 
type of healthcare-oriented CAAT -- clinical audit software like Auditmaker or PCS Clinical Audit Tool -- 
uses existing clinical care databases to generate aggregate data about the quality of physician practice, 
to improve patient outcomes and compliance with standards of care [121-123].  
All these audit software packages focus on analyzing an existing, electronic dataset for errors 
and unusual patterns, rather than facilitating the comparison between the dataset and a physical source 
document. Indeed, in many accounting and security audits, the electronic database is the source 
document and no other records exist. As a result, these advanced software packages are not helpful for 
auditing paper source documents. Furthermore, the high cost of tools such as ACL, IDEA, and UMTAudit 
makes purchasing them unfeasible in resource-limited settings [124].  
We believe a CAAT specifically designed for research data auditing can improve the process of 
source document verification. This project aims to (1) identify the core weaknesses of paper forms when 
used for clinical data auditing, (2) develop a set of functional requirements for a computerized audit 
tool, (3) implement the necessary requirements in a prototype audit system, and (4) test the resulting 
application during six data audit visits at participating HIV clinics. The CAAT desiderata and 
implementation are described in subsequent sections. 
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Motivation 
Study Setting 
The Caribbean, Central and South America Network for HIV epidemiology (CCASAnet) brings 
together researchers from Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru to investigate 
region-wide trends in the HIV epidemic [82].  Participating HIV clinics contribute de-identified, routine 
patient care data for proposed studies and the separate datasets are merged by the network’s data 
coordinating center (DCC), housed at Vanderbilt University.  
To ensure the reliability and completeness of study data, the DCC conducts routine Good Clinical 
Practice-based audits of the datasets submitted by CCASAnet member sites. During such audits, a small 
team of clinicians and informaticians visits each member clinic to compare the on-site medical 
documentation to the contents of the electronic dataset the site previously submitted for analysis.  
Paper-based Audit Process 
The first CCASAnet audit circuit was completed in April 2008 and included seven baseline site 
audits and one re-audit. During all eight visits, the audit team used a multi-page paper audit form to 
record the results of the database-to-clinical record comparison.  Data on the form were divided into 
categories including demographics, clinical visit data, antiretroviral regimens, and laboratory results. The 
form contained two preprinted items for each data element: the name of the variable (e.g., birth date, 
date of death, viral load result), and the corresponding value from the site’s submitted database. The 
team used the blank “audit value” field to record whether a data element was present in the source 
documents and whether the source value was correctly represented in the database. A small notes field 
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– as well as the margin of the paper – was used to record additional information or possible causes of 
the error. Figure 7 shows a sample page of a completed audit form. 
 
Figure 7: A neatly completed paper form from a CCASAnet site audit 
This scanned image shows the first page of a multi-page paper audit form used for on-site CCASAnet audits. 
At the end of an audit visit, the auditors presented their preliminary findings during an exit 
interview with the site investigator and staff. After returning to the DCC, the audit team reviewed the 
audit forms, categorized and tabulated the data errors, and produced a report describing its findings and 
recommendations, which was sent to the site for review and comment. The audit team inspected 210 
randomly selected records and 4,686 unique data elements during eight audits.  
Limitations of Paper-based Audit 
CCASAnet’s paper-based audit process relied heavily on memory, interpretation, and opinion, 
and was difficult to replicate and standardize across sites. Although the auditors were not noticeably 
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frustrated with the paper form during the audit, the loose structure of the paper audit form allowed 
ambiguity during data collection. When the DCC undertook a reevaluation of the audit findings in mid-
2008, the auditors had a difficult time classifying the data discrepancies according to a formal error 
taxonomy because the original paper forms had required auditors only to describe and correct errors. Of 
210 original audit forms assessed during the reevaluation, 30 (14%) contained auditor notes that were 
partly illegible and 56 (27%) contained underspecified error descriptions that made error coding 
challenging. Figure 8 depicts such a record with unclearly documented audit findings. Furthermore, the 
average time between the end of an audit and the completion of the audit report was 101 days, which 
meant the site data personnel rarely received immediate, implementable recommendations on how to 
improve data quality.  
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Figure 8: A messy paper form from a CCASAnet site audit 
This scanned image shows the final page of a CCASAnet paper audit form. The form contains markings by three 
different auditors and demonstrates the problems of unclear handwriting, ambiguous documentation of audit 
conclusions, and the challenge of post-audit error coding. 
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In post-audit debriefings, the auditors identified several causes for delays in producing the audit 
report, including difficulties with 
 managing multiple audits and reports simultaneously, 
 interpreting partially or incorrectly completed audit forms, 
 assessing whether observed data discrepancies were clinically meaningful, 
 assigning audit codes to different types of errors after the audit, 
 consulting with other auditors about error classifications or unclear information, 
 reading other auditors’ handwriting on completed audit forms, 
 interpreting underspecified auditor notes without the presence of the source documents, 
 sharing a single set of original, paper audit forms among a team of auditors, 
 tabulating errors, 
 double-checking other auditors’ error tables, 
 calculating error rates, 
 composing a thorough and detailed audit report, and 
 formatting error tables for the final document. 
 
Feedback on data quality is most effective when it is communicated shortly after the audit takes 
place, but the use of paper audit forms made generating accurate and timely reports a challenge [62]. 
We hypothesized that a computer-assisted audit tool that replaced the paper forms had the potential to 
reduce the number of indecipherable or ambiguous audit findings and increase the timeliness and 
reproducibility of audit results. Our study examined the feasibility of CAAT-based auditing in resource-
limited settings by determining the desirable functions of a computerized audit tool, implementing 
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these features in a CAAT prototype, and testing the resulting application during the second CCASAnet 
audit cycle. 
Key Attributes of an Audit Tool 
Through a review of experiences documented during the initial audits, post-audit debriefings, 
and audit-related discussions with the DCC and CCASAnet sites, we identified five key areas in which a 
computer-assisted audit tool could improve the audit process: networking, audit data management, 
standardized error assessments, audit decision support, and results reporting [125]. The audit team’s 
experiences that motivated these requirements are described in the text. The requirements are outlined 
as desiderata in Table 9. 
Networking 
Our discussions and review identified an effective CAAT as a networked application that could 
accommodate multiple, simultaneous users. Paper forms had functioned as an excellent sharing tool 
during audits. Although each auditor worked independently on a set of records, difficult cases or records 
with cascading errors often required group review in which the source document and paper audit form 
were passed around the table. A suitable CAAT needed to facilitate the same real-time communication 
between multiple auditors. It had to allow collaborative editing of a single copy of the data, as web-
hosted applications do, but could not be hosted remotely at the DCC because (1) Internet access was 
unstable or unavailable at some CCASAnet sites, and (2) long network delays (high latency) between 
webservers in the U.S. and CCASAnet sites in the Southern Cone would result in a lag-prone user 
experience. A suitable audit tool needed to take advantage of alternate network structures, such as 
locally hosted applications and wireless ad hoc networks between auditor laptops.  
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Audit Data Management 
Generating paper audit forms in advance of each audit was a laborious, multi-day task for the 
audit team and the CCASAnet data manager. If an audit tool could generate web forms dynamically by 
combining user-designed form templates with pre-formatted datasets, the preparation time would 
decrease, especially when evaluating the same template at multiple sites. A standard XML data 
specification would permit auditors to load a copy of the audit data, as provided by the study data 
manager, before the audit began. A standard for data import/export would allow a copy of the audit 
results to be delivered to the auditee in an electronic format. 
Standardized Assessment of Errors 
The paper audit forms prompted auditors only to record and describe errors during the on-site 
audit; errors were counted and categorized by type during the preparation of the audit report. An 
effective CAAT would prompt auditors to assess and categorize errors during the audit visit, rather than 
weeks afterward when the source documents were no longer accessible.  
Audit Decision Support 
Selecting the number and type of records to audit can be a challenge for novice auditors. The 
CCASAnet audit team consulted a statistician in advance of each audit, but a useful CAAT could provide 
basic guidance on sample size calculations and selecting records for audit, using selection metrics that 
have been described in the literature. Contingent on additional studies of error types, it might be 
possible to incorporate decision support for error classification; a mismatched weight value of 57.5kg in 
the clinical record vs. 58kg in the database, for example, is likely to be a rounding error of limited clinical 
significance. This functionality could be useful in labeling complicated errors of drug prescription and 
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discontinuation. A CAAT with full decision support capabilities could also provide post-audit 
recommendations based on the numeric audit results.  
Results Reporting 
The CCASAnet team found that preparing a post-audit report from paper audit sheets required 
tedious and time-consuming work. Both auditors needed to count the variables in each record, group 
any recurring errors, double check final numbers, and tabulate the results manually, which delayed 
preparing the final report. Software support to tally errors and generate tables could allow auditors to 
present an accurate summary of findings during the exit interview as well as simplify the production of a 
post-audit report.  
All five desiderata are listed in a table on the next page. 
System Design 
Setting 
The network’s second audit cycle began in April 2009 with the submission of new datasets for 
studies of cancer and tuberculosis (TB) in HIV-positive persons. Data abstractors at each CCASAnet site 
identified cases of TB and cancer in local clinical charts and entered related demographic, diagnosis, and 
treatment-related data into REDCap, a secure, web-based application for research data entry [102]. 
REDCap featured separate, multi-page forms for TB and cancer data entry and separate databases for 
each site. The template for each form could be exported from REDCap as a data dictionary in comma-
separated-values (CSV) format, specifying the form fields, their accompanying labels, a coded value set 
(if applicable), and the appropriate HTML form element (checkbox, text field, and dropdown list). The 
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de-identified, observational data entered into REDCap could also be exported in CSV format with one 
line per record.  
 
Table 9: Desiderata for a computer-assisted tool for data audits 
Obstacles Encountered during Audits Solutions / Desiderata for a Computer-Assisted Audit Tool 
Challenge: Collaboration Solution: Networking 
Auditors need to work collaboratively on the same 
copy of a record. 
Real-time Collaboration: networked laptops for auditors, 
shared databases, web-based systems 
Audit sites may have no network infrastructure. Portable Network Infrastructure: peer-to-peer networking, 
portable server and router 
Challenge: Audit Data Solution: Audit Data Management 
Paper audit forms take a long time to prepare and 
validate. 
Import Functionality: one-click import of data and data 
descriptions (metadata) from research database to CAAT, 
instant generation of basic electronic audit forms 
Copying audit results from paper forms into a 
spreadsheet for analysis is time-consuming. 
Export Functionality: export of audit results into structured 
data formats (e.g., CSV, XML) 
Datasets may contain different medical content 
(e.g., HIV, Tuberculosis, or cancer data). 
Metadata Management: customizable display of data on 
screen, data dictionaries for special topic areas (HIV, TB, 
Cancer) 
Challenge: Types of Errors Solution: Standardized Assessment of Errors 
Errors are not categorized and described clearly on 
paper forms, making it difficult to analyze and 
report error types and rates. 
Representation of Error Types: categorization of errors, 
clear operational descriptions of error types, specification 
of domain of error types (applies to specific variables within 
the audit record or applies to entire record) 
Challenge: Audit Design and Conduct Solution: Audit Decision Support 
Auditors are unsure how many records should be 
audited to produce meaningful results.  
Statistical Dashboard: guidance for sample size calculations, 
identification of grossly problematic records, pre-selection 
of records via statistical sampling 
Auditors may not know which recommendations to 
offer based on audit findings. 
Results-based Recommendations: automated suggestions 
for quality improvement measures based on classes of 
errors detected in the data. 
Challenge: Analyzing and Presenting Results  Solution: Results Reporting Tools 
Tallying and tabulating errors by hand is a time-
consuming and error-prone task for auditors. 
Automatic Error Tabulation: software support for 
generating tables and graphs 
Sites enjoy receiving copies of the individual record 
audit forms. 
Automatic Form Generation: software support for 
producing printable forms that mirror the format of 
completed paper audit forms. 
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The second-round audits were conducted at nine separate locations, including clinic libraries, 
hospital conference rooms, record review rooms in the hospital archive, and public office spaces. Three 
locations had reliable, broadband internet access, two had slow and intermittent access, and the 
remaining four had no internet access. 
Implementation 
The DCC needed an audit system that could accommodate the cancer and TB datasets 
submitted by every site, while we endeavored to adhere to the CAAT desiderata we had established. We 
implemented the networking attribute by designing a web-based application that was hosted by an 
Apache 2.2 webserver running on one auditor’s laptop computer [126]. We coded the web application 
in PHP and implemented dynamic user interface elements using the jQuery JavaScript library [127,128]. 
The audit data were stored in a parallel MySQL 5 database [129]. Users connected to the webserver 
using available local area networks at the CCASAnet clinics. When Internet access was unavailable, the 
audit team established a computer-to-computer network between auditor laptops. After the completion 
of the audit, we relocated the application files to a secure Vanderbilt webserver, so all auditors could 
access the electronic audit records while preparing a post-audit report.  
The REDCap system simplified our approach to audit data management since we received each 
site’s cancer and TB dataset in a standardized, CSV export format.  We had previously encoded the 
structure of our cancer and TB case report forms in order to generate data entry forms in REDCap for 
interested sites. We developed a metadata import function that reused these field descriptors to 
construct the layout of our audit forms. Appendix B provides examples of our CAAT data import format 
and data dictionary, both based on the REDCap data specification. 
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To maintain comparability with our previous audits, we implemented the European 
Organization for the Research and Treatment of Cancer (EORTC) error classification system described in 
Chapter III, where code 1 represents correct data and codes 2-5 represent minor errors, major errors, 
missing data, and sourceless data, respectively. When auditors flagged data discrepancies, we prompted 
them to code the error type based on a dropdown selection from the EORTC list.  
We chose not to implement audit decision support for this prototype since we already received 
our lists of records to be audited from the biostatistician who had designed our previous audits. We 
acknowledge that automatic tools for selecting audit records would be a valuable CAAT feature, but we 
would not have had occasion to test it using our established audit methodology. We also lacked the 
necessary root cause data to build an audit decision support module that could offer quality 
improvement recommendations based on numeric audit findings.  
We automated the post-audit tabulation of errors using a results reporting system that 
calculated the frequency of error types as well as overall error rates. Since our auditees were 
accustomed to paper audit forms, we also generated a printable document displaying our audit findings 
in the familiar format. 
Application Walkthrough 
We present the reader with a descriptive walkthrough of our prototype CAAT to illustrate our 
implementation choices and the application’s functionality. All screenshots presented in Figure 9 though 
Figure 15 were taken in Mozilla Firefox 3.6. 
Our prototype CAAT had five core modules that were linked from the application’s homepage 
(Figure 9): data upload, record selection, record auditing, report generation, and application 
configuration. 
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Figure 9: Screenshot of the homepage of SimpleAudit, a prototype computer-assisted data auditing tool 
This screenshot shows the homepage of our data auditing application in a web browser. The five core modules are 
displayed: data import, audit record selection, auditing, report generation, and application configuration. 
 
Figure 10: Screenshot of the data import screen 
The Data Import screen has forms for uploading two content files: a dataset from which records can be selected 
for auditing and a data dictionary describing the structure of the record file. 
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The Configuration module handled user and audit setup, allowing the audit manager to create 
new audit events, label imported datasets, register new users, assign passwords, and track logins. 
The Data Import module transferred research datasets into the audit system. The upload form, 
shown in Figure 10, prompted the user to upload the data dictionary and dataset as exported from 
REDCap. The data dictionary determined the labels for the variables and order of the pages of the 
auditing form. The application then parsed the data and metadata files and stored the contents in 
several entity-attribute-value database tables, where each form field and data element was assigned a 
unique ID. Incorrectly formatted research datasets generated alerts that halted the import process and 
prompted the user to manually repair the data files. In the last step of pre-audit preparations, the 
auditor designated a subset of records for on-site review. The Record Selection screen (Figure 11) 
displayed a list of all imported record IDs and allowed the user to choose specific records by ID number. 
We selected records according to a list provided by our biostatistician, but if we had implemented 
decision support for record and sample size selection, it would have been incorporated in this module.  
Once on-site, auditors tested the audit support capabilities of the CAAT. The home screen of the 
Auditing module, seen in Figure 12, displayed a list of all the records that had been selected for review, 
along with the name of the dataset being audited and the method used to select the record. Once 
auditors signed off on the review of a record, the link to that record was moved from the “Incomplete 
Records” to the “Completed Records” list. 
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Figure 11: Screenshot of the audit record selection page 
Auditors choose records for auditing (from a list of all uploaded records) using the page-right checkboxes.  
 
Figure 12: Screenshot of the listing of records to be audited 
All the records that have been selected for auditing are listed on the Record Display page. Records move to the 
bottom list once auditors mark that record “complete.” 
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Auditors interacted primarily with the main audit screen pictured in Figure 13. Each audit record 
had a customized, dynamically generated audit form. The ID of the audit record was displayed 
prominently at the top of each page, followed by hyperlinks to the different pages of the audit form. 
 
Figure 13: Screenshot of the data audit interface 
The computer assisted audit tool provides a custom, dynamically generated web form for each audit record. The 
image above depicts a partially audited example record, whose ID number, 86497-22, is shown in bold red font at 
the top of every page of the form. The form above has three pages: General Info, TB Diagnosis, and TB Therapy, 
followed by the record completion page. In the example above, an auditor has noted an error for the variable “Risk 
factor for HIV,” by checking the box in the red “error” column, indicated by the ‘-‘ heading. This action causes an 
extra row, shaded in red, to expand below the checkbox. The fields in the extra row allow the auditor to record 
additional information about the error. In the example above, the auditor has also marked “ID number” as 
incorrect. The corrected value and the error code are shown in the “CR value” column. 
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The audit interface was a simple five-column form listing the label for the data element (e.g., 
Date of birth, Sex, Risk factor for HIV), the value the site had submitted to the DCC (“DB value”), a space 
for the value the auditors identified in the clinical record, if different (“CR value”), and two checkboxes 
to mark a correct value (“+”) or an error (“-“). When an auditor checked the error column, the web form 
expanded to add a temporary row for entering error details, shown with a red background in Figure 13. 
This sub-form prompted auditors to enter a corrected value and code the type of error according to the 
classification developed by the EORTC, described in Chapter III. The error form also contained a text field 
for auditor notes. 
Once an auditor finished verifying all necessary data elements in a given record, he marked the 
record as “audited” using the record completion form shown in Figure 14.  
 
Figure 14: Screenshot of the record completion screen 
Once an auditor has completed his review of a record, he marks the record complete by selecting the green 
“complete” box pictured above. Alternate selections include “unaudited” for records that were available but not 
audited (yellow box) and “unavailable” (red box) for records that the site could not locate or provide. 
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Fully reviewed records were marked as “audited.” Alternate completion labels included 
“unaudited” for records the team received but lacked time to audit and “unavailable” for records the 
site could not locate or provide during the audit period. Selecting any of these three options moved the 
record to the “Completed Records” section of the record list. The final Reporting module assisted 
auditors with summarizing the audit findings and preparing a report for the sites. The CAAT 
automatically tabulated the number of correct, incorrect, missing, and no source document errors from 
records marked “audited” and highlighted error rates over 10% in red, as shown in Figure 15. It also 
generated printable forms, shown in Figure 16, that displayed the audit findings in the format of the 
original paper audit forms (shown previously in Figure 7 and Figure 8).  
 
Figure 15: Screenshot of the audit summary report 
The audit summary table displays a list of the audited data elements and a numeric summary of the audit results. 
The report lists the number of times each type of variable was audited, the number and percentage of correct data 
elements, the number of data elements that were incorrect, missing, or lacking source documents, and the 
variable-specific error rate. Table cells with error rates higher than 10% are highlighted in red in the far right 
column. 
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Figure 16: Automatically generated audit forms 
The CAAT automatically generated these printable forms based on the imported data, imported form template, 
and auditor findings. 
The final system contained five core modules that supported users during the preparation for, 
conduct of, and reporting of a clinical research data audit. We implemented four of our five proposed 
CAAT desiderata in this prototype. 
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User Experience 
The application configuration presented no problems; we hosted the webserver on an auditor 
laptop running Windows XP. All sites except Site C had submitted data through REDCap and these data 
and metadata files presented no import problems. Site C’s dataset generated minor formatting alerts 
that prompted us to correct the data file contents. Our estimates suggest this application decreased the 
average audit preparation time to less than one hour (from greater than six hours). 
The auditors were pleased with the physical convenience of using a CAAT as it freed us from 
transporting both a laptop and up to three pounds of paper audit forms during travel and site visits. 
Desk space on-site was also limited, and auditors favored placing a laptop on the table rather than paper 
forms that occasionally vanished under piles of clinic charts. Electricity for charging laptop batteries was 
available at every audit site. (On the other hand, the auditors did find the CAAT was not as useful as the 
paper forms for swatting mosquitoes.) 
The web application had a low response time when handling auditor requests over most clinics’ 
local area networks, but difficulties arose in locations with unreliable internet access. The computer-to-
computer network was unstable, sometimes requiring several computer reboots before our laptops 
would connect. We discovered the ad-hoc network configuration was not robust enough to handle more 
than two auditor laptops; with three simultaneous users the poor response times from the webserver 
made the application unusable.  
Typed text eliminated illegible auditor notes and the CAAT promoted immediate rather than 
post-audit coding of all data errors. Auditors used the results reporting module to present numeric audit 
results during the exit interview, generate tables for the audit reports, and generate printable results 
forms. These forms improved the transparency of CCASAnet audits by allowing site personnel to see our 
conclusions for each record and variable. 
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Our informal evaluation indicated that this prototype application decreased the average audit 
preparation time to less than one hour (from more than six hours), increased auditor compliance with 
documentation and coding, eliminated the transcription of audit results, and provided sites with more 
detailed audit results.  
Discussion 
Summary of Findings 
When an audit process lacks standardization, as our original paper-based audits did, different 
auditors may produce different audit reports given the same source record. Without standardized 
quality measures, the changes in an organization’s data quality cannot be compared from year to year, 
nor can audit results be compared from site to site. We described five desirable attributes for a flexible 
audit support tool designed to simplify and standardize auditors’ work, including multi-user support 
through networking, file formats for importing and exporting audit data, standard error assessment 
protocols, audit decision support, and tools for calculating and displaying audit results.  
Our prototype system demonstrated the significance of these key attributes as well as the 
feasibility of implementing them in a simple web-based application. We tested our CAAT during audits 
of twelve cancer and tuberculosis datasets in nine locations and found the system drastically improved 
the audit process by decreasing preparation time from over six hours, on average, to less than one hour; 
enforcing consistent, on-site error coding for all records; and eliminating difficulties reading other 
auditors’ completed forms, as well as manual error tallying for the post-audit report. 
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Limitations 
The CAAT recommendations we describe stem from audit experiences at HIV clinics in Latin 
America and the Caribbean. The perspective of a single international research network, however, may 
limit the diversity of experiences that informed the five suggested requirements. Indeed, for single-user 
audits, a desktop application or other non-networked solution might present less complexity. 
Considering multidisciplinary audit teams are more common and effective [130].we believe these 
recommendations represent a necessary though perhaps not sufficient set of features needed for a 
successful paperless audit tool.  
Additionally, our CAAT was limited in both its implementation of our proposed key attributes 
and its general applicability. We elected not to implement the fourth attribute, Audit Decision Support, 
as it was redundant given our audit circumstances and we were unable, therefore, to evaluate its 
usefulness in the field. We also did not write installation instructions or support documentation as the 
system was a prototype. A full-fledged application should include such support tools and 
documentation.  
Our approach to importing audit data and form designs as REDCap CSV files saved several hours 
of preparation time as we had already designed the electronic form templates to create REDCap data 
entry interfaces for CCASAnet sites. Other users wishing to audit datasets for which no REDCap form 
templates exist would need to create them and would therefore not benefit from these time savings. 
Nevertheless, the REDCap data and metadata files are built using a straightforward design and coding 
process (as shown in Table 15 and Table 16 of Appendix B), and require no expertise beyond typing a list 
of variable names, labels, and form element codes into an MS Excel spreadsheet. We believe designing 
one such template for several audits of identically formatted data is much faster than creating new 
paper audit forms for each site. 
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We also recognize the effectiveness of the REDCap-motivated audit interface is dependent on 
the structure of the audit data. As we determined during the initial paper-based audits, correcting errors 
in antiretroviral regimen data often requires auditors to rearrange the order of regimens and insert new 
fields to accommodate additional data points. The TB and Cancer datasets we reviewed using the CAAT 
contained no variables that were as order-dependent as ARV regimens. Such data would require 
extended user interface option, possibly with Javascript widgets that allowed drag-and-drop duplication 
and reordering of medication regimens.  
We were unable to conduct a quantitative comparison between the efficiencies of the paper-
based and CAAT-driven audit processes because the HIV dataset we audited on paper differed from the 
TB and Cancer datasets. The quantity and types of data elements varied among datasets, as did the 
types of source documents we reviewed to validate them. The auditors had also developed greater 
auditing skill and knowledge of the domain by the second round of audits, which would have biased the 
results in favor of the audit tool. 
Conclusion 
Audits are an important quality assessment and intervention, but paper audit forms complicate 
the audit process, during the preparation for and conduct of the audit, as well as the post-audit analysis. 
We identified five attributes that would allow a computer application to replace paper audit forms: 
computer networking for simultaneous application use by multiple auditors, standard formats for 
importing data and metadata, a structured approach to classifying data errors, support for pre-audit 
record selection, and the automatic tabulation of audit results. Our prototype CAAT conformed to these 
specifications and measurably improved the efficiency of our source document reviews. Furthermore, 
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use of an electronic system enforced consistency in our audit forms, error coding, and error tallying, 
which likely improved the comparability of our audit results across sites. 
After extending the user interface to handle different types of data and completing a cycle of 
code refactoring, we intend to test the applicability of this simple, computer-based audit tool in 
networks outside of CCASAnet and on datasets of non-HIV data. These steps will allow us to evaluate the 
validity and comprehensiveness of our five CAAT desiderata and identify extensions to the application 
that increase its potential for general use. Our experiment demonstrated that a computerized audit tool 
can simplify the audit process and enable research networks to measure and improve the quality of 
their data. We hope other similar networks will find a computer-based auditing approach useful for 
evaluating the quality of their data, standardizing their quality control activities, and identifying areas for 
process improvement. 
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CHAPTER VI 
EVALUATING DATA QUALITY DIMENSIONS IN THE CONTEXT OF CLINICAL RESEARCH 
DATA AUDITS 
Introduction 
Comparing the quality of research data generated by different clinical sites requires a thorough 
and standardized method of classifying characteristics of the audited data, especially properties related 
to data inconsistency and error [53]. Unfortunately most error classification schemes are designed for a 
specific task and lack generalizability [23]. The U.S. Department of Defense, for example, maintains a list 
of codes for labeling specific discrepancies in military inventory and accounting data [131], while the 
National Coordinating Council for Medication Error Reporting and Prevention offers a specialized 
taxonomy for tracking medication errors in healthcare organizations [132]. Other healthcare error 
taxonomies focus on medical device errors, patient safety, adverse events, and quality of care [133-136]. 
Information quality researchers have derived a detailed “taxonomy of dirty data” using theoretical 
principles and constructed informal taxonomies based on expert opinion, but their classification systems 
model errors within enterprise data warehouses and not discrepancies between medical research data 
and their physical source documents [137,138]. 
Clinical researchers often judge the quality of study data by their accuracy and completeness. 
Such aspects of quality that require use of different techniques to measure or document them are often 
referred to as dimensions of data quality [139]; over 26 different dimensions are noted in the scientific 
literature, with accuracy and completeness among the most cited [20]. Kahn et al., for example, defined 
twelve dimensions of quality relevant to information stored in product and consumer databases: 
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accessibility, appropriate amount of information, believability, completeness, concise representation, 
consistent representation, ease of manipulation, free-of-error, interpretability, objectivity, relevance, 
reputation, security, timeliness, and “value-added” [24]. Redundant naming schemes are rampant, 
however; studies by Wang, Kriebel, and Kahn use the terms accuracy, correctness, and “free-of-error” 
respectively to refer to truthful and accurate data [24,140].  
Data quality is a context-dependent concept and what comprises data quality-related 
information for clinical source document verification audits -- beyond assessments of accuracy and 
completeness -- is not well documented in the literature [141]. We believe understanding data quality 
dimensions relevant to clinical research data auditing can facilitate more effective quality control 
processes. Auditors can design better audit methodologies, prioritize evaluation of the most relevant 
aspects of data quality, and capture quality-related information in a consistent, standardized format. 
Strong and Wang have proposed a framework for identifying aspects of data quality that are relevant to 
end users by examining organizations’ quality assessment projects and using qualitative analysis to 
identify patterns of data quality problems [141].  
We explore the application of this framework to identify a set of quality features relevant to 
clinical research data auditing. This study examines the quality assessment projects conducted by the 
CCASAnet coordinating center and attempts to determine what quality attributes auditors consider 
when determining whether data are fit for use. 
Study Subject: CCASAnet Audit Datasets 
The CCASAnet project aims to create a shared repository of HIV data from participating sites in 
Latin America and the Caribbean and to use the combined data to “answer questions about the 
characteristics of the regional HIV epidemic” [82]. Current CCASAnet membership consists of HIV/AIDS 
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centers at seven hospitals and clinics in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru, plus a 
data coordinating center (DCC) at Vanderbilt University in Nashville, USA. A team from Vanderbilt 
conducted on-location, source verification data audits of datasets submitted to the DCC in response to 
proposed CCASAnet projects. 
The CCASAnet DCC audited four distinct datasets, labeled HIV, HIV-study, Cancer, and 
Tuberculosis (TB) between 2007 and 2010. The HIV dataset submitted by each participating CCASAnet 
clinic included all HIV-positive, treatment-naïve patients beginning HAART, as well as an unlimited 
number of data points for demographics, treatment history, opportunistic infections, and laboratory test 
results. The site determined the contents and format of the variables, usually based on the structure of 
the local research database. The second dataset, HIV-study, contained excerpts from the HIV dataset 
that were reformatted by the sites and the DCC for use in two core CCASAnet research projects. Site 
personnel constructed the remaining two datasets, Cancer and TB, for two CCASAnet-specific projects 
on malignancy and tuberculosis in HIV-infected individuals. All data were numeric, categorical, and text 
data, rather than multimedia (e.g., images, video). 
The DCC provided structured case report forms for the cancer and TB projects and site 
personnel submitted the data using REDCap’s web-based data collection forms. The DCC conducted all 
HIV, Cancer, and TB data audits; site personnel and the DCC audit team independently audited the HIV-
study datasets. 
For all paper-based audits, auditors noted data errors and quality concerns by recording a 
corrected value and any necessary descriptive comments. Error codes, listed in Table 10, were applied 
to the data post-audit. For all computer-based audits, auditors coded errors on-site and recorded 
corrected values and comments using the CAAT web forms. Auditors could determine a particular value 
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was in error (using a specific error code) and optionally add quality-related comments.  Values that were 
labeled as correct (code 1) could also generate quality-related comments.   
 
Table 10: EORTC audit codes 
Numeric audit codes from the European Organization for the Research and Treatment of Cancer, and code 
definitions adapted for audits of clinical research databases. 
Audit 
Code EORTC Definitions (adapted for an audit of database content) 
1 correct: data in the database fully corresponds with the information in the medical file 
2 minor error: database value does not correspond with information in the medical file, but the 
discrepancy is of minor clinical significance 
3 major error: database value does not correspond with information in the medical file and the 
discrepancy is clinically significant 
4 missing/missed: requested data are missing in the database 
5 sourceless: data are present in the database, but not in the medical record (impossibility of checking 
correctness of the data) 
Methods 
We conducted a retrospective review of all audit forms completed during three years of 
CCASAnet data audits at member sites in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru. For 
the original HIV and HIV-study audits we reviewed paper forms; for audits of the Cancer and TB 
datasets, we reviewed the data entry screens and printouts from the computer-assisted audit tool 
described in Chapter V. We inspected data types and values, error classifications, and auditor notes, 
both notes specific to individual data points as well as free text comments about each record as a whole. 
Variables included demographics, clinical data (e.g., weight, HIV staging, clinic visit dates), laboratory 
tests (e.g., CD4 lymphocyte count, HIV viral load, hemoglobin, TB culture, or biopsy results), ARV or TB 
medication regimens, cancer treatments, and all associated dates. 
For each record, we noted whether the error ratings and auditor notes suggested information 
on data quality that was not captured in a structured or standardized fashion by the audit process. We 
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counted recurrences of similar auditor observations and grouped them by themes using a bottom-up 
approach. Finally, we attempted to map our quality themes to the 26 most frequently cited dimensions 
of data quality, as described in the data quality dimension literature reviews of Wand and Knight 
[20,142]. 
Results 
Our manual review of audit documentation covered 520 audit forms that had been completed 
during 25 on-site audits by four auditors from the DCC and five internal auditors at CCASAnet sites A, D, 
E, and G. Of the audit documents, 378 were paper forms and 162 were printouts from the computer-
based audit tool (Table 11). These forms contained audit findings for approximately 17,000 variables. 
 
Table 11: Sources and types of audit documentation included in data quality review 
*Totals are not additive due to overlap; CCASAnet comprises only seven sites and the same DCC audit team 
participated in every dataset audit. 
Dataset 
Audit 
Sites Auditors 
Forms 
Reviewed Format 
Cancer 6 3 72 electronic 
TB 6 3 90 electronic 
HIV 7 3 223 paper 
HIV-study 4 8 135 paper 
Total 7* 9* 520 
 
 
We identified 597 auditor comments or markings in the audit documents that reflected quality 
issues not captured by our error classification system. Not all quality comments were attached to data 
errors, and not all data errors had auditor comments. These observations represented 18 categories of 
quality comments and included auditor notes about the quality and type of source documents, date 
estimations, duplicate values, and predictions of the error source. 
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We mapped 17 categories to eight different dimensions of data quality: reputation (the degree 
of respect for the data’s quality based on the information source), precision (the degree of exactness 
with which a value is stated), consistency (the degree to which data are “presented in the same format 
and compatible with previous data”), relevance (the degree to which data are “applicable and helpful” 
for the study), timeliness (the degree to which the data are “sufficiently up-to-date” for the study), 
objectivity (the degree to which data are “unbiased, unprejudiced, and impartial”), conciseness (the 
degree to which the data are “compactly represented without being overwhelming”), and clarity (the 
degree to which data are “easily comprehended” and understandable without ambiguity) [140,142]. 
Descriptions of the auditor observations we identified, their related dimensions of data quality, and the 
number of observations in each category are shown in Table 12. 
Of the auditor observations, 173 (29%) reflected confidence in or concern for the quality and 
types of source documents against which the data were being validated. The majority of these 
comments indicated what type of source document was used to confirm a data point (“mentioned in 
visit note” or “confirmed by laboratory database”) or qualified an auditor’s “no source” declaration 
(code 5) by noting whether he’d conducted a cursory or an exhaustive search before applying the label. 
Other auditors used margin notes to remark on temporarily unavailable source documents. One site, for 
example, could only provide the audit team with clinic charts and not the corresponding hospital charts 
because employees in the hospital records office were on strike. The auditors noted the problem but 
chose not to label affected data with error codes because it would inflate the site’s true “no source” rate 
and diminish the usefulness of audit findings.  
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Table 12: Types of data quality observations not captured by the standard audit protocol, their frequency, and 
related data quality dimensions 
This table lists the 18 categories of quality-related observations we found in our review CCASAnet audit documents 
as well as their description, frequency, percentage of 597 total comments, and related dimension of data quality. 
Dimension Observation N (%) Description of quality comment 
Reputation Quality or Type of 
Source Document 
92 (15%) Notes mention what type of source document provides proof 
of data validity or error (e.g., lab report, flowsheet, clinic 
intake sheet, clinic note, etc.). 
 Partial Sources 29 (4.9%) Only partial source documents are available (e.g., clinic chart 
but not hospital chart). 
 Auditor Search 
Intensity 
52 (8.7%) "No source" (code 5) assignments include a statement of how 
thoroughly the auditor searched for a source document in the 
CR. 
Precision Rounded Values 65 (11%) Values are rounded although exact measurements are 
available. 
 Approximations 45 (7.5%) DB contains approximate values even though exact ones are 
available in the CR, or approximate values aren't labeled as 
such. 
 No Dates 19 (3.2%) Lab values, patient ages, or other data points that require a 
date to have meaning have no associated date. 
 Overprecision 27 (4.5%) Data are reported with false exactness 
 Preferable Value 18 (3.0%) Other lab values are better choices given the specified 
timeframe. 
Consistency Inconsistent 
Definitions 
43 (7.2%) The definitions for this value vary depending on who recorded 
the information. 
 Inconsistent 
Formats 
38 (6.4%) Data are recorded using inconsistent codes or syntax (e.g., 
alternating date formats, male/masculine/M) 
 Conflicting Data 27 (4.5%) The dataset lacked internal consistency; some values 
contradicted other values. 
Relevance Inclusion of Record 21 (3.5%) The record does not meet the study's inclusion criteria and 
should not be present in the dataset. 
 Irrelevant Data 4 (0.6%) The record contains unnecessary information that is not 
required for any study and was not requested by the DCC.  
Timeliness 
 
Outdated Data 24 (4.0%) The record hasn't been updated in many years despite new 
information, or the record isn't as current as suggested by the 
"last update date" variable. 
Objectivity Interpreted Data 14 (2.3%) The variable contains interpreted data rather than raw data. 
(i.e., Instead of a numeric lab value, field says "normal"). 
Conciseness Duplicates 3 (0.5%) The dataset included multiple, redundant instances of a single 
value. 
Clarity Vague Data 8 (1%) The meaning of a value was ambiguous without extra data. 
N/A Prediction of Error 
Cause 
68 (11%) Miscellaneous auditor comments speculating on potential 
causes of error (e.g., typographical slip, distorted rubber date 
stamp) 
Total 18 types 597 (100%)  
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An additional 174 (29%) audit comments noted imprecise representations of data, including 65 
cases of weight, creatinine, and hemoglobin measurements that had been rounded to the nearest 
integer (and sometimes not the nearest integer, as in a case of 76.8 kg rounded down to 76 kg.) Other 
instances of imprecision occurred when site personnel submitted medication regimens with 
approximated start and stop dates despite having exact dates documented in on-site pharmacy records. 
The case report forms for the Cancer and TB data collections requested laboratory values “at baseline,” 
defined as a 30-day window preceding HIV or TB treatment start, and site abstractors occasionally 
submitted valid but non-optimal data selections for these data. In one case, the record abstractor chose 
a viral load result taken 28 days before baseline over a value from 2 days before baseline. While the 
submitted, 28-day value was not incorrect, the 2-day result more precisely represented “viral load at 
baseline.” 
We also noted 27 observations of false precision in the audit data. Two sites frequently failed to 
identify estimated dates despite a checkbox on the data collection form indicating “this date is an 
approximation.” The resulting data points falsely appeared to be exact dates. A third site’s data 
submission contained CD4 cell counts and hemoglobin measurements with two decimal place precision 
even though the laboratory reported only integers; a CD4 value of 98 cells/mm3 was stored as 98.44 in 
the database. (The site’s data manager later established that the data distortions were due to faulty 
coding in the lab-to-database import script.) 
The third most common category of auditor observations concerned the consistency of data 
encountered during the audits, particularly in data definitions, data representation, and dataset content 
(108 auditor comments, 18%). In 43 cases, clinicians recorded assessments of hepatitis B infection or HIV 
staging using definitions that did not correspond with the majority of the dataset’s records. In one site’s 
dataset, most “patient HIV stage” variables were coded using World Health Organization criteria, but a 
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few cases used criteria published by the U.S. Centers for Disease Control and Prevention instead 
[143,144]. Two medical record abstractors from a different CCASAnet clinic correctly interpreted the 
“Site & Subsite” prompt of the Cancer report form as referring to the part of the body where the cancer 
was located. The third abstractor mistook the prompt (“Site”) for a question about the hospital where 
the cancer was diagnosed. 
Additionally, 38 records from two datasets in our review recorded semantically identical data 
content with alternating, inconsistent syntax, using character strings like “M,” “male,” or “masculino” to 
represent the same “patient gender” concept, or “<80,” “79,” or “0” to code an undetectable viral load. 
Other auditors noted contradictory values in audit material, such as visit dates after the patient’s death 
or opposing variables such as “HAART naïve” and “previous HAART” both coded as “yes.” 
Auditor observations concerning the relevance or timeliness of data each occupied four percent 
of the data quality comments. In 25 cases, records failed the inclusion criteria for their respective 
datasets and data were irrelevant to the proposed studies. In another 24 cases, the patient information 
submitted to the DCC was extremely outdated and not as recent as the record’s “last update date” 
variable suggested. One patient had died six months prior to a planned record update, but two years 
later his death was still not reflected in his electronic file. 
Physicians’ interpretations compromised data objectivity in 14 cases; affected variables 
contained interpreted data rather than raw data.  Lab results, for example, were recorded as "normal" 
rather than numeric values. Our retrospective review also detected three cases in which auditors 
remarked upon a lack of concise data representation, particularly with duplicate data points. In 8 
remaining quality-related observations, auditors copied additional information from the clinical record 
to compensate for lack of clarity in the audit data. 
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We also identified 68 records that contained auditor notes concerning potential causes for 
observed errors. These included typographical mistakes in case report form-to-database transcription, 
incorrectly sorted lab slips, or misshapen rubber date stamps that inked illegible numbers. 
Discussion 
Summary of Findings 
Our analysis identified eight dimensions of data quality that were ineffectively captured using 
either the traditional paper audit or the computer assisted audit tool, namely the clarity, timeliness, 
concise representation, consistent representation, objectivity, relevance, precision, and reputation of 
the data. Almost a third of the audit observations concerned the trustworthiness of the data relative to 
the quality of the source document. The auditors’ comments reflected awareness that an original lab 
slip confers greater trust in the accuracy and authenticity of a laboratory result than a handwritten 
doctor’s note in the patient record. However, the “no source” (code 5) error classification was only a 
dichotomous measure of data reputation. Auditors also hesitated to label a variable with a code 5 error 
if they had not exhaustively searched the clinical record for a potential source document. The quantity 
of such observations suggests auditors require a more granular measure of data reputation, both to 
code quality observations and manage auditors’ time, as data elements with low relevance to study 
outcomes may not necessitate an exhaustive search for documentation. 
Other deficiencies of the datasets, such as inconsistent variable representations, outdated 
content, and imprecise data could delay or bias the results of research studies: when such errors are 
apparent, study progress is delayed until research sites provide the coordinating center with data 
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corrections; alternately, the study could be compromised by poor quality data and investigators might 
remain unaware until subsequent data quality inspections. 
Limitations 
Our study investigated the dimensions of data quality relevant to source document verification 
audits in the context of an observational research network for HIV epidemiology composed of member 
sites in resource-limited settings using paper-based medical records. Without additional investigation, 
we cannot know whether the aspects of data quality we identified generalize to source verification 
audits of other datasets in other settings. Indeed, analyzing audits of clinical sites whose primary source 
documents are electronic systems may reveal additional dimensions of data quality that affect whether 
the resultant datasets are fit for use.  
One researcher identified all quality-related comments in the audit documents and assigned 
them to classes of “audit observations” and “data quality dimensions.” Validation by a second analyst 
would increase the legitimacy of these results. 
This retrospective documentation review likely underestimated the variety of quality 
dimensions in clinical research data audits. We are certain auditors did not document every data quality-
related comment, but they are likely to have recorded the most critical or frequently occurring quality 
observations. Our findings, therefore, may represent a critical but not exhaustive list of data quality 
dimensions relevant to source verification auditing. Collecting feedback from auditors during the audit 
process might increase the numbers of observations and reveal additional categories of error. 
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Conclusion 
Our study established that auditors consider dimensions in addition to accuracy and 
completeness when determining whether study data are fit for use. Clinical research data auditing 
involves at least eight additional data quality dimensions, including reputation, precision, consistency, 
relevance, timeliness, objectivity, conciseness, and clarity. The EORTC error coding system includes only 
dichotomous markers of accuracy, completeness, and “existence of source document,” and therefore 
cannot represent the complexity of these additional dimensions. This limitation leads auditors to record 
their observations as free-text notes.  
By capturing additional dimensions of data quality formally and routinely, auditors can better 
characterize quality variances among sites and offer suitable recommendations. When observing 
inconsistencies in data definitions or formatting, for example, auditors can suggest the affected site 
develop a handbook of standard operating procedures for data recording and capture. Since regular 
assessment of all relevant dimensions could burden auditors with memorizing lists of data error types 
and frequent quality observations, prompts and tools to assess such dimensions should be incorporated 
in an auditing CAAT. The error coding form of the system described in Chapter V might include a 
dropdown selection for “source type/quality”, a slider bar for “intensity of auditor search”, or a user 
tagging system to mark unnecessary approximations or probable typographical slips.  
Source verification audits like those conducted by CCASAnet could render comprehensive and 
informative results more efficiently if relevant data quality dimensions were captured in a standardized 
fashion. Auditors could benefit from a deeper understanding of what aspects of quality render a dataset 
fit for use.  A comprehensive quality assessment framework for clinical research data auditing must be 
flexible and enable auditors to measure and record many observations on data quality beyond simple 
measures of accuracy and completeness. 
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CHAPTER VII 
DISCUSSION 
Summary of Findings 
Patient records maintained by healthcare providers offer an abundance of longitudinal medical 
data that potentially can be reused for research. Such data fuel the studies conducted by many large, 
global consortia, including major regional cohorts that have been established to address treatment and 
outcomes in HIV-positive persons. The process of transforming patchwork hospital and clinic 
documentation into uniform, formatted research data is challenging, particularly in resource-limited 
settings where data are often of poor quality. Nevertheless, investigators rarely conduct systematic data 
quality assessments when the record abstraction occurs outside the strict monitoring programs of 
clinical trials or when pre-existing databases are recycled for new studies.  
We conducted a series of source verification data audits to determine the accuracy and 
completeness of data submitted to CCASAnet, an international, multicenter observational research 
network for HIV epidemiology. Our analysis identified rates of missing weight measurements, 
unverifiable laboratory values, and discrepancies in antiretroviral treatment regimens and dates that 
would have triggered quality violations and immediate intervention in the context of controlled clinical 
trials. Database integrity checks performed at the DCC would not have identified most of these errors, 
since the data appeared normal and internally consistent. These findings illustrated a pressing need for 
on-site data quality assurance activities in networks like CCASAnet.  
Local research teams reported on potential sources of flawed data in a post-audit survey, 
naming difficulties with the syntax and semantics of the data and the culture of the workplace. Although 
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the direct causes of missing source documents or data were often identical across sites, the root causes 
were site-specific, resulting from limited clinic resources, workflow complications, or the hostility of 
external participants towards research activities. The sources of error identified by site personnel 
informed future predictions of error causes documented by the DCC audit team.  
Our initial audit experiences underscored the limitations of paper audit forms for standardizing 
and reporting audit findings. We analyzed the CCASAnet audit process to identify key attributes for a 
computer-assisted audit tool, which included networking, audit data management, standardized error 
assessment, decision support, and results reporting tools. We developed a prototype application based 
on these desiderata and piloted it during six audits of tuberculosis and cancer data from CCASAnet 
clinics. Our informal assessments suggested the CAAT improved the efficiency, clarity, and completeness 
of our data audits. 
Finally, we cataloged issues in data quality that were not adequately represented by standard 
measures of accuracy and completeness. We discovered auditors made margin notes related to eight 
additional dimensions of data quality, especially the precision of data, consistency of representation, 
and reputation of the source document. These findings clarified what makes CCASAnet data “fit for use” 
and suggested additional functionality for our computer-based audit application. 
Study Limitations 
Throughout this work we have treated the patient medical record as a gold standard for data 
quality, which is standard research data practice [55]. Medical records, however, are not complete 
histories of patient care due to differences in how individual doctors collect patient histories, conduct 
physical exams, interpret lab results, and document these activities [145]. A study by Rethans et al. 
found the correlation between the number of actions physicians took during patient consultations and 
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the number of actions documented in subsequent clinical notes was only 0.54, while the documentation 
provided insufficient information to measure clinician performance in clinical audits [146]. Abstraction 
of such incomplete medical records may introduce more errors [147]. Since medical records portray an 
incomplete picture of patient care, our audits may have underestimated the true rates of data variability 
and error in submitted datasets. 
Even when using a standardized error classification system, as we did with the 5-stage quality 
codes from the European Organization for the Research and Treatment of Cancer (EORTC), different 
approaches to labeling errors and counting the total number of data fields (for the denominator of the 
error rate) can result in notably different error rates [49]. The error rates reported in Chapter II, the 
questions asked of each site in the Chapter III survey, and the frequency of auditor observations 
documented in Chapter VI could be affected. We have attempted to minimize variations in the 
application of EORTC codes by making one person responsible for the initial coding of all errors reported 
here, with other auditors reviewing the work to confirm consistency and correctness. 
The limited perspective of this research also affects its external validity; CCASAnet was the 
setting for all audits and all datasets were related to the care of HIV-positive persons. Audit experiences 
with other collaborations and datasets might reveal additional categories of data error, desiderata for 
an audit tool, and relevant dimensions of data quality. 
Although we have confidence in the effectiveness of auditing, we cannot demonstrate that our 
quality assessment procedures have had a measurable impact on data quality at CCASAnet sites as we 
did not study the impact of reporting our audit findings or implementing local quality interventions. 
Although our eventual goal is to improve provider documentation and research data procurement 
measurably at CCASAnet sites, simply providing investigators with estimates of the error rates in their 
study data can have a positive impact on their data selection and study design [148]. 
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Study Implications and Future Work 
This project represents innovative work in the field of audit informatics. The collection of studies 
presented here comprises an initial effort to detail data quality problems in HIV observational datasets 
and to describe, simplify, and standardize the audit process for clinical research data. Our findings 
should encourage observational networks to establish central data monitoring programs and guide clinic 
sites in conducting routine quality assessment activities.  
Future work will seek to quantify the costs of auditing in observational research networks, while 
exploring innovative low-cost approaches. We also intend to develop and distribute an open source 
software application for data quality auditing and formally evaluate its effectiveness in comparison to 
paper-based audits. Our prototype application proved effective and the work described in Chapters IV 
and VI provided additional auditing insights to guide the development of a comprehensive CAAT. Sites 
without a trained data manager could benefit from using such an application to establish an internal 
quality assessment program. By observing diverse applications of the software, we can assess whether 
the audit tasks and relevant aspects of data quality we have described generalize to settings beyond 
CCASAnet. 
Verifying data against source documents through audits will improve the quality of databases 
and research and can be a technique for retraining staff responsible for clinical data collection.  Audit 
efforts may be optimized by using software that supports key audit functions and allows documentation 
of diverse data errors. We recommend that all participants in observational cohorts use computer-based 
data audits to assess and improve the quality of data and to guide future data collection and abstraction 
efforts at the point of care. 
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APPENDIX A 
EXAMPLE OF AUDIT FORM AND ERROR CODING 
Table 13: Example of the Demographics and Laboratory Data sections of a completed audit form  
This sample form demonstrates how errors in clinical and laboratory data are coded and documented when 
auditors identify values in clinical records that conflict with those recorded in the database.  
Test Record #1 Value in database 
Value in clinical 
record 
Comments Audit Code 
Demographics and clinical data 
Gender Male Male  correct (1) 
Birthdate 1973-01-31 1973-01-31  correct (1) 
Weight 56 56.5 Rounding minor error (2) 
Weight date 24 Aug 2002 24 Aug 2002  correct (1) 
Laboratory data 
CD4 --- 110  missing (4) 
CD4 date --- 15 Aug 2002  missing (4) 
Viral load 32,000 320,000 Probable typo incorrect (3) 
Viral load date 15 Aug 2002 15 Aug 2002  correct (1) 
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Table 14: Example of the Antiretroviral Regimens sections of a completed audit form  
This sample form demonstrates how ARV errors are coded and documented when auditors identify values in 
clinical records that conflict with those recorded in the database.  
Test Record #1 Value in database 
Value in clinical 
record 
Comments Audit Code 
 Regimen 1 AZT DDI RIT SAQ AZT DDI RIT SAQ  correct (1) 
 Start date 28 Aug 2002 28 Aug 2002  correct (1) 
 Stop date 09 May 2006 06 Feb 2005 
Notes from the HIV clinic 
show that regimen 1 was 
stopped on 06 Feb 2005. 
Only the Tuberculosis clinic 
continues to report regimen 
1 active until 09 May 2006. 
incorrect (3) 
 Regimen 2 --- AZT 3TC EFV  missing (4) 
 Start date --- 06 Feb 2005 
(documented in hospital 
orders and notes from HIV 
clinic) 
missing (4) 
 Stop date --- 01 Jan 2006  missing (4) 
 Regimen 3 --- D4T 3TC EFV KAL  missing (4) 
 Start date --- 14 Feb 2006 
Regimen 3 began during 
hospitalization and is listed 
as dispensed on hospital 
orders checksheet 
missing (4) 
 Stop date --- 21 Feb 2006 
Regimen 3 stops appearing 
in hospital orders. 
missing (4) 
 Regimen 4 D4T 3TC KAL D4T 3TC KAL  correct (1) 
 Start date 09 May 2006 22 Feb 2006 
Regimen 4 was begun on 22 
Feb 2006 during 
hospitalization and 
(according to the order 
sheets) the drugs were 
administered. 
incorrect (3) 
 Stop date 19 Sept 2006 23 Jul 2006 
Clinic notes show Regimen 4 
was stopped on 23 Jul 2006. 
incorrect (3) 
 Regimen 5 AZT 3TC KAL AZT 3TC KAL  correct (1) 
 Start date 19 Sep 2006 18 Sep 2006 Unclear handwriting. minor error (2) 
 Stop date current/ongoing 11 Dec 2007 Patient died. incorrect (3) 
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APPENDIX B 
EXAMPLES OF CAAT METADATA AND DATA SPECIFICATIONS 
Table 15: Example of CAAT metadata specifications 
This table presents an example of the data dictionary format imported by the computer-assisted audit tool (CAAT) 
described in Chapter V. Each row describes how to display one element on the web form shown in Figure 13 (see 
page 62).These specifications are based on the REDCap metadata format. 
Variable /  
Field Name Form Name 
Section 
Header Field Type Field Label Choices 
Field 
Note 
study_id demographics  text Study ID   
person_identifier demographics TB Case 
Abstract 
Form 
text ID number   
dob demographics  text Date of birth  MM/DD/
YYYY or 
YYYY-
MM-DD 
dob_estimate demographics  advcheckbox Is the date above an 
estimate? 
0, Unchecked | 1, Checked  
sex demographics  dropdown Sex 0, Male | 1, Female | 2, 
Transsexual 
 
bcg_history demographics  dropdown History of BCG 
vaccination 
0, Yes | 1, No | 2, Unknown  
bcg_scar demographics  dropdown BCG scar 0, Yes | 1, No | 2, Unknown  
transmission demographics  dropdown Risk factor for HIV 0, Heterosexual | 1, 
Homosexual | 2, Bisexual | 3, 
IDU | 4, MTCT | 5, Other 
 
transmission_other demographics  text Other: (describe 
here) 
  
usual_occupation demographics  text Patient's usual 
occupation 
  
 
Table 16: Example of CAAT data specification 
This table presents an example of data formatted for import into the computer-assisted audit tool. Categorical 
variables are coded according to lists of choices defined by the metadata format shown in Table 15. 
study_ 
id 
person_ 
identifier dob 
dob_ 
estimate sex 
bcg_ 
history 
bcg_ 
scar transmission 
transmission_ 
other 
usual_ 
occupation 
1 test1 12/28/1981 0 0 1 1 1 
 
taxi driver 
2 test2 4/7/1974 0 0 2 2 3 
  
3 test3 2/15/1954 1 0 2 2 1 
  
4 test4 1/13/1949 0 1 2 2 0 
 
sex worker 
5 test5 11/23/1971 0 1 2 2 0 
  
6 test6 11/2/1981 0 0 2 2 2 
 
stylist 
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